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ABSTRACT 
FARR, T. Effects of hypoxia on exercise induced muscle damage. 
Purpose: The present study investigated the hypothesis that maximal voluntary 
contractions (MVC) peak torque, VJ, muscle tenderness, and plasma creatine activity 
would be significantly less for the condition that subjects were exposed to hypoxic (H) 
condition for 4 hours after eccentric exercise compared with the normoxic (N) condition. 
Methods: Methods: Sixteen male subjects performed 60 repetitions (6 sets x 10 reps) of 
maximal eccentric action of the knee extensors on their dominant leg (knee joint angle 0o – 
90o at 9o s-1) to induce muscle damage. Subjects were then randomly assigned into hypoxic 
(H) (15.5% O2) or normoxic (control, CON) conditions. Two hours after the eccentric 
EIMD protocol, subjects rested in H (4hr treatment of breathing a medical grade gas 
(15.5% O2 and 84.63% N2)) or N (4hr treatment of breathing ambient air) group. Maximal 
isometric strength (MVC), maximal isokinetic peak torque, muscle soreness, plasma 
creatine kinase (CK) activity and vertical jump (VJ) were measured 24, 48, 72, 96 & 120hr 
post-eccentric EIMD protocol. Hypothesis: The recovery of MVC, peak torque, VJ, 
muscle tenderness, and plasma creatine activity would be significantly less during the H 
versus CON conditions. Results: Each dependant variable was compared between the 
groups and times by a two way repeated measures ANOVA. Plasma CK and tenderness 
was not significantly different between the H and CON conditions. Although tenderness 
was greater in the H condition to that of the N condition at 48 & 72hr post-EIMD whilst 
soreness was significantly greater in the H condition compared to the N condition at 24hr 
post-EIMD (p<0.05). MVC at 35O showed a significant difference between the H and N 
groups at 48hr (p<0.05). MVC at 55O showed a significant difference (p<0.05) between H 
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and N groups percentage change at 72hr post-EIMD. MVC at 75O showed no significant 
differences between the H and N group at any of the measurement times. Maximal 
isokinetic concentric strength at 60O.s-1, 120O.s-1 and 240O.s-1 was not significantly different 
between H and N groups although the N groups measured variables were consistently 
greater across time. Similarly VJ showed no significant difference between H and N 
groups. Conclusion: The result of the present investigation suggests that the effect of a 4hr 
H insult following eccentric EIMD did not retard muscle damage or affect recovery 
process. However, further investigation is required to provide conclusive evidence that 
muscle damage recovery is affected by H insult following exercise.  
 
Key words: hypoxia, normoxia, normobaric, eccentric exercise, partial oxygen pressure 
(PO2), creatine kinase (CK), muscle soreness, muscle tenderness. 
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CHAPTER ONE     
 
INTRODUCTION 
 
1.1 Background to study 
Numerous studies (Ernsting, 1963; Ernsting, 1978; Ernsting & Sharp, 1978; Cable, 
2003; Harding, & Mills, 1983; Robergs, Quintana, Parker & Frankel, 1998) have 
previously investigated hypoxia and the physiological effects experienced at high altitude. 
However, to date the effects of hypoxia on muscle damage recovery has not previously 
been investigated. Exercise, especially unaccustomed strenuous activity, most often, results 
in muscle damage and is characterized by soreness, tenderness and a reduction in normal 
levels of strength and power, on the day after the activity and may last for up to 48hr 
(Clarkson, Nosaka & Braun, 1992; Clarkson & Tremblay, 1988; Ebbling & Clarkson, 
1989). Therefore, this study chose eccentric EIMD as the protocol to investigate the effect 
of H condition on muscle damage as an eccentric exercise bout consisting of 60 eccentric 
actions would produce muscle damage and characteristics similar to previous studies.  
Elite athletes currently engage in post-game recovery methods, immediately 
following a game and possibly 24hr post-game. These methods include walking, jogging, 
stretching, massage, contrast immersion (hot/cold baths) and either/or pool activities such 
as swimming, walking/running, active stretching or a combination of methods (T. Farr, 
personal observation). However, the effects of a short bout of hypoxia, usually within 24hr 
post-game, whilst flying from one competition to the next competition has, to date, not 
been addressed by medical or fitness staff employed by athletes. Anecdotal evidence 
suggests exercise induced muscle damage (EIMD) recovery is delayed following short-term 
(4hr) air-travel. A group of elite athletes from Western Australia who travel by aircraft (2-
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6hr) every second weekend during their competition period reported greater mental and 
physical fatigue and reduced training performances, following *4-48hr after high-intensity 
exercise. It is also hypothesised that those athletes who regularly travel by air for a period 
of not less than 4hr have a reduced competitive career compared to those who travel 
infrequently by air. (T. Farr, personal observation). 
The recovery time following exercise induced muscle damage is possibly dependent 
on the oxygen (O2) supply to the damaged tissues as the human body is extremely sensitive 
and vulnerable to the effects of hypoxia, which can result in the deterioration of bodily 
functions, organism necrosis and eventual death (Ernsting & Sharp, 1978, p. 45). Therefore, 
O2 may be considered to be the most important component required for the maintenance of 
normal bodily functions and the repair of damaged tissue. Previous investigations by 
Robergs, Quintana, Parker & Frankel, 1998; Ernsting, 1963; Ernsting, 1978; Ernsting & 
Sharp, 1978; Cable, 2003, have presented information on the effects high altitude (hypoxia) 
has on the human physiology at high altitude however, these studies only assessed healthy 
individuals at various altitudes.  
The potential benefits of post-game muscle damage recovery may be compromised 
by short term exposure to hypoxia, similar to that which is experienced during air-travel. 
Aircraft cabins are usually pressurized to a relative hypobaria of 560 mmHg and exposes 
travellers to a moderate hypoxia (15.4% O2), equivalent to a reduction in atmospheric 
oxygen of approximately 5.5% (20.93% at sea level) (Harding & Mills, 1983). Reducing 
muscle damage recovery time increases the return to pre-game physical condition and a 
more rapid return to training and provides a more effective pre-game training session, 
which may result in improved performance. However, as stated, the effects of hypoxia on 
muscle damage recovery, has not been investigated previously.   
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1.2 Purpose of the study        
The purpose of this investigation was to compare the effects of a 4hr normobaric 
hypoxia and normobaric ambient air insult on muscle damage recovery following a 
bout of eccentric exercise. The current study may clarify relationships between 
muscle strength, muscle function and normobaric hypoxia. The rationale for the 4hr 
intervention period was that anecdotal evidence suggests that hypoxic exposure, 
whilst traveling by aircraft, of less than 4hr has no physiological effect on muscle 
damage recovery or training performance.    
 
1.3 Research Question 
1.3.1 Does short term (4hr) exposure to normobaric hypoxia following eccentric 
exercise induced-muscle damage exacerbate recovery of muscle damage? 
 
1.4 Hypotheses 
1.4.1   Blood creatine kinase activity, muscle soreness and muscle tenderness would 
be greater in the hypoxic condition than the normoxic condition across time 
whilst the recovery of isometric muscular strength, peak torque, vertical 
jump height, would be significantly retarded after the hypoxic condition 
compared to the normoxic condition. 
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1.5 Abbreviations 
CO2   : Carbon Dioxide 
EIMD: Exercise Induced Muscle Damage 
FIo2  : a fractional concentration of oxygen in the inspired gas. 
ft      : feet; the measure of a distance 
H+     : Hydrogen ion 
H      : Hypobaric 
N      : Normobaric 
O2     : Molecular Oxygen 
Pco2  : Partial pressure of CO2  
pH    : Potential Hydrogen; a scale representing the relative acidity     
           or alkalinity of a solution. A value of 7.0 is neutral, below 7.0  
           is acid, and above 7.0 is alkaline. The numeric pH value   
           indicates the relative concentration of hydrogen atoms in the  
           solution compared to a standard solution (Mosby, 1990).    
PIo2  : inspired oxygen tension 
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CHAPTER TWO     
 
LITERATURE REVIEW 
 
This literature review will focus on the body of published literature in the areas of 
hypoxia and the physiological effects of hypoxia. It then explores the oxygen therapies in 
association with comparison of the known association between treatment of severe trauma 
of skeletal muscle tissue and muscle damage recovery and the mechanisms that induce 
muscle damage.  
 
2.1   Hypoxia  
Hypoxia is the inadequate or reduced tension of O2 in the arterial and capillary blood, 
whether in quantity or molecular concentration (Ernsting, 1963). Hypoxia is a phenomena 
characterized by cyanosis, tachycardia, hypertension, peripheral vasoconstriction, and 
mental confusion (Mosby, 1990, p. 598). Mild hypoxia may cause (hypoxic drive) low 
arterial oxygen pressure, which stimulates the peripheral chemoreceptors to increase heart 
and respiratory rates. If the amounts of oxygen are not adequate for aerobic cellular 
metabolism, energy is provided by less efficient anaerobic pathways that produce 
metabolites other than carbon dioxide (Mosby, 1990, p. 598). The human body is extremely 
sensitive and vulnerable to the effects of severe hypoxia, which can result in the 
deterioration of bodily functions, organism necrosis, and eventual death (Ernsting, & Sharp, 
1988, p. 45). Hypobaric Hypoxia is a reduced molecular concentration of oxygen in the 
inspired air produced by a decrease in barrometric pressure (Ernsting & Sharp, 1988, p. 45). 
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Normobaric Hypoxia is the inspiration of 15.37% oxygen (medical grade gas) in an isolated 
chamber at sea level. 
Living organisms obtain energy to maintain their biological functions by the oxidation 
of molecules of food substances, such as the conversion of glucose to water and carbon 
dioxide (Ernsting & Sharp, 1978, p. 45). The present investigation is concerned with 
hypoxic hypoxia and its physiological effect on muscle damage recovery, as a consequence 
of air-flight. Aircraft cabins are usually pressurized to a relative hypobaria (hyperbaric 
hypoxia) of 560 mmHg, which is equivalent to between 5,000 and 7,000 feet (ft). This 
hypobaria equates to a moderate hypoxia, equivalent to a reduction in atmospheric oxygen 
of 5.5% (20.93 to 15.4%).  
 
2.2  Physiological Responses to Hypoxia 
The energy required to maintain biological processes is obtained from the oxidation 
of complex chemical foods to simpler compounds whilst producing CO2, water and other 
waste products. Oxygen is therefore possibly the most important component required for 
normal human function. The human physiological system is designed to function most 
efficiently and economically at sea level to maintain general requirements of the pulmonary 
and respiratory systems. In the event an individual is exposed to altitudes above sea level 
the physiological function of that individual may be altered.   
Ernsting & Sharp (1978, p. 47) suggest that the increase in pulmonary ventilation 
that occurs as a result of exposure to altitudes above 8,000-10,000ft may be a result of two 
conflicting factors: the lowered arterial oxygen tension which stimulates ventilation and its 
effect on the chemoreceptors of the carotid and aortic bodies. However, the increase in 
ventilation is opposed by the respiratory depressant effect of the concomitant reduction in 
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carbon dioxide tension. The compromise between the two factors is the demand for an 
adequate oxygen supply versus the need to maintain a normal acid-base balance. During 
exposure to hypoxia, at rest, pulmonary ventilation increases at altitudes above sea level, 
induced by inspired air during air-travel, producing small insignificant increases in the total 
oxygen consumption, and in carbon dioxide production, of the tissues (Ernsting & Sharp, 
1978, p. 48). This increase in metabolism is a consequence of the extra work associated 
with the rise in pulmonary ventilation and cardiac output (Ernsting & Sharp, 1978, p. 48). 
In addition to the previous studies, Harding & Mills, (1983) investigated aviation 
pilot’s performances of coordination tasks, and memory challenges following a number of 
tests. Features of hypobaric hypoxia, which occurs during ascent to altitude, include subtle 
personality change, euphoria, impaired judgement, short-term memory loss and mental in-
coordination. Furthermore, Ren, Fatemian, & Robbins (2000) suggest the features 
associated with hypoxia vary between individuals, and the rate at which they develop 
depends on the severity of the hypoxic insult. These features reflect the ability of the 
cardiovascular and respiratory systems to respond to hypoxia. If the hypoxic environment 
were to vary in oxygen concentration between aircraft carriers an athlete may be at risk if 
they have a soft tissue injury as they may be more susceptible and sensitive to any change 
in oxygen quality or quantity as they are highly trained and exceptionally fit individuals. 
Similarly, it may be hypothesized that the athlete is more likely to be able to adjust 
accordingly to the environment as their cardiovascular system is highly trained to cope with 
any physical challenges with regard to oxygen availability and delivery to the physiological 
requirements. Therefore, it seems reasonable to investigate if there are any effects of 
hypoxia on muscle damage recovery in an attempt to answer unknown questions. 
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Hypoxia alters the hemoglobin affinity for oxygen. Increases in Pco2 and H+ 
decrease oxyhemoglobin saturation; a decrease in pH from 7.4 to 7.3 at 40 torr Po2 
decreases the oxyhemoglobin saturation by 6% and this is particularly significant in the 
capillaries of working muscles (Mosby, 1990, p.160). However, It is unsure if these effects 
will occur during a hypoxic insult of 5,000 to 8,000ft. If the exercise intensity was great 
enough to cause significant tissue damage, increases in Pco2 and H+ may cause hemoglobin 
affinity for oxygen to be further altered when exposed to a hypoxic condition.  
Exposure to a hypoxic environment will cause a proportional increase in cardiac 
output, to that of heart rate (HR), although stroke volume remains constant (Ernsting & 
Sharp, 1978, p. 51). Although cardiac output increases, mean arterial pressure during 
moderate hypoxia is usually unchanged to that of breathing air at sea level. The systolic 
blood pressure usually increases with pulse pressure, although there is an overall reduction 
in peripheral resistance, a redistribution of blood flow by local and vasodilatation responses 
(Ernsting & Sharp, 1978, p. 52). An immediate increase in blood flow through the coronary 
and cerebral circulation, whilst the peripheral resistance in resting skeletal muscle is 
unchanged and renal blood flow is significantly reduced (Ernsting & Sharp, 1978, p. 52). 
The redistribution of cardiac output to essential organs, heart and brain, is increased at the 
expense of less acutely essential organs such as, viscera, skin and kidneys (Ernsting & 
Sharp, 1978, p. 52).   
Jones, Sutton, Taylor, and Toews (1977) investigated the effects of pH on 
cardiorespiratory and metabolic responses to exercise and showed that sodium bicarbonate 
supplemented subjects maintained a power equivalent to 95% of maximal rate of oxygen 
consumption for twice as long as the control group. The ammonium chloride subjects 
showed half the endurance time at the same power output. However, a further study showed 
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that the effects were caused, in part, by changes in muscle glycolytic flux (Sutton, Jones & 
Toews, 1981). McCartney, Heigenhauser, and Jones (1983) employed an identical 
experimental approach to manipulate blood acid-base status to investigate the effects on 
maximal short-term (anaerobic) cycling. In contrast to the previous study, McCartney, 
Heigenhauser & Jones (1983) found that the reductions in blood pH were associated with 
only small reductions in the total work performed in 30s of maximal exercise. The authors 
concluded that the blood acid-base alterations have an insignificant effect on short-term 
maximal performance mediated by changes in glycolytic flux. However, any variation 
between the two investigations methodologies may reflect the subject(s) ability to maintain 
the oxidation of lactate within the muscle (or the muscle of the resting limb), or an increase 
in gluconeogenesis during exercise may indicate fatigue, or insufficient stores of CP within 
the muscle would reduce the ability to maintain maximum total work output over time 
during anaerobic exercise.  
Ahlborg, Hagenfeldt, & Wahren, (1975), Sutton, Jones, & Toews, (1981) have 
shown that lactate uptake by muscle, liver and other tissues increases during prolonged 
exercise and following a period of recovery. However, Richardson, Noyszewski, Leigh, & 
Wagner, (1998) suggest it is controversial whether lactate formation during progressive 
dynamic exercise from sub-maximal to maximal effort is due to muscle hypoxia. The 
authors investigated muscle hypoxia using a direct measure of arterial and femoral venous 
lactate concentration, a thermodilution blood flow technique, phosphorus magnetic 
resonance spectroscopy (MRS), and myoglobin (Mb) saturation measured by 1H nuclear 
MRS in six trained subjects performing single-leg quadriceps exercise. They calculated net 
lactate efflux from the muscle and intracellular PO2 with subjects breathing ambient O2 and 
12% O2. Mb saturation was significantly lower in H compared to N throughout incremental 
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exercise to maximal work rate. The authors found the net blood lactate efflux was unrelated 
to intracellular PO2 across the range of incremental exercise to maximum but linearly 
related to O2 consumption with a greater slope in 12% O2. The net lactate efflux was also 
linearly related to intracellular pH. The authors concluded the increasing work rate, at a 
given fraction of inspired O2, lactate efflux is unrelated to muscle cytoplasmic PO2, yet the 
efflux is higher in hypoxia and that catecholamine values from similar studies indicate that 
lactate efflux in hypoxia may be due to systemic rather than intracellular hypoxia.  
Diminished oxygen delivery to the kidney as a result of hypoxia exposure, 
diminished red cell mass, or reduced renal blood flow results in increased erythroproietin 
(EPO) production (Fried & Morley, 1985). To determine the duration of continuous 
exposure to normobaric hypoxia required to increase EPO production, Knaupp et al (1992) 
measured plasma EPO levels in subjects exposed to acute normobaric hypoxia for 5, 60 and 
120min and examined the EPO response to intermittent hypoxic exposure for 240min. The 
investigation showed no increase in EPO after 5 and 60min exposures. However, a 50% 
increase was seen 240min after the initiation of the 120min hypoxic exposure. Intermittent 
exposure resulted in an increase of EPO by 52% 360min after the onset of exposure. They 
concluded that exposing humans continuously to a hypoxic condition for 120min or 
intermittently for 240min provides a sufficient stimulus to increase EPO production.  
Consideration of subject plasma volume should be considered when evaluating these 
results, as individual sensitivity to decreases in plasma volume and exposure to hypoxia 
conditions and fitness levels may explain any disparity between the observed values.   
However, it is possible that hypoxia exposure may result in a decrease in the oxygen 
content of arterial blood (PaO2). This decrease in PaO2 and the subsequent decrease in O2 
diffusion gradient between blood and tissue may be the primary effect of hypoxic insult. A 
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secondary effect of the hypoxic insult that may inhibit the treatment of soft tissue injury is 
the increased inflammatory response possibly due to a PO2-mediated vasoconstriction. 
After damaged tissue fragments have been cleared neutrophils and their state of function 
may be reduced, macrophages are then recruited by chemotactic agents to mediate the 
processes of growth and repair which may be reduced due to the hypoxic insult.   
 
2.3   Oxygen Therapy 
Hyperbaric oxygen therapy (HBO) is an accepted treatment of crush, burn and trauma 
injuries and skeletal muscle compartment syndromes (Bouachour, Cronier, Gouello, 
Toulemonde, Talha, & Alquier, 1996; Cianci & Sato, 1994; Strauss, Hargens, Gershuni, 
Greenberg, Crenshaw, Hart, & Akeson, 1983; Strauss, Hargens, Gershuni, Hart, & Akeson, 
1986). Garcia-Covarrubias, McSwain, Van Meter, & Bell (2005) suggest HBO therapy has 
been recommended as an adjunct treatment in acute traumatic ischemia and crush injury 
and concluded that adjunctive HBO is not likely to be harmful and could be beneficial if 
administered early. HBO therapy has also been advocated for the treatment of severe 
trauma of the limbs in association with surgery because of its effects on peripheral oxygen 
transport, muscular ischemic necrosis, compartment syndrome, and infection prevention 
(Bouachour, Cronier, Gouello, Toulemonde, Talha, & Alquier, 1996) . 
Staples, Clement, Taunton, McKenzie (1999), Ishii, Deie, Adachi, Yasunaga, 
Sharman, Miyanaga, & Ochi (2005) suggested HBO has become a prescribed treatment for 
athletes suffering soft tissue injuries because of the oxygen transport effect.  Specifically, 
Staples et al., (1999) suggested that intermittent exposures to HBO may provide the 
opportunity to reduce recovery from delayed-onset muscle soreness (DOMS). In support of 
the use of HBO as a treatment for muscle injury recovery, Ishii et al, (2005) suggested that 
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HBO treatments have been reported to reduce post-injury swelling and provides a positive 
result for tissue remodeling after injury.  
Several investigations indicate a potential for HBO treatment for reducing recovery 
time. In HBO studies, greater increases in eccentric torque and decreases in fatigue and soft 
tissue injury recovery time have been demonstrated in HBO treatment groups compared to 
other treatments groups (Bouachour et al, 1996; Staples, Clement, Taunton, McKenzie, 
1999; Ishii et al, 2005).  HBO therapy was administered over a 5-day period in two phases; 
the first phase four groups (control, hyperbaric oxygen treatment, delayed treatment, and 
sham treatment) showed a significant difference between the treatment group and the other 
groups for eccentric torque recovery, in phase two three groups (3 days of treatment, 5 days 
of treatment, and sham treatment) showed eccentric torque recovery for the 5-day treatment 
group was significantly greater compared to the sham group from immediately after 
exercise to 96hr after exercise (Staples et al, 1999).  
In support of HBO treatment, Ishii et al, (2005) suggest that HBO treatment assists 
muscle injury recovery as oxygen is crucial during recovery from injury and physiological 
fatigue. By performing HBO treatment, more oxygen is dissolved in the plasma of the 
pulmonary vein via the alveolar, increasing the oxygen reaching the peripheral tissues. 
Therefore, it is expected that HBO treatment may reduce recovery time from injury and 
fatigue. Similarly, Sueblinvong, Egtasaeng, & Sanguangrangsirikul, (2004) found that 
HBO treatment of 30 minute exposure to 2.5 ATA with 100% O2-inhalation on lactate 
concentration following muscular fatigue from incremental exercise on a cycle ergometer 
resulted in a significant decrease of blood lactate concentration at 15, 20 and 25 minutes 
post exercise intervals in the hyperbaric recovery group (HR) compared to rest recovery 
group (RR), oxygen recovery group (OR), and the hyperbaric oxygenation (HBO2). 
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Interestingly these results may initiate HBO therapy as a relatively quick treatment for 
recovery following fatigue in sports requiring repeated high intensity efforts. Although 
there has been reports of reduced post-injury swelling and tissue remodeling after injury, 
with injuries involving bones, muscles and ligaments showing improved recovery. HBO 
therapy may be ethical and moral as a treatment for trauma injuries and other injuries 
sustained however, the question of HBO therapy relevance, ethical and moral use during a 
sporting competition should be investigated and trialed before promoting it’s use. 
Despite its potential, HBO treatment does have its risks. Increasing oxygen levels in 
tissues poses a risk to DNA through oxidative damage, which can lead to pathological 
changes in the CNS and the lungs. Groger, Speit, Radermacher, & Muth (2005) 
investigated HBO, pure oxygen breathing at supra-atmospheric pressures, and suggested it 
represents a well-suited model for investigating oxidative stress-induced DNA damage as 
well as protective mechanisms. They concluded that both heme oxygenase-1 blockade and 
excess nitric oxide release promote DNA damage during HBO exposure in vivo. Regarding 
the operating of HBO systems, safer administration should be advised. Further research into 
HBO treatment is required if this therapy is to become more widespread. However, Ishii et 
al, (2005) suggest “it should become possible to tailor treatment to an individual's condition 
in order to use HBO treatment efficiently”.  
In contrast to the previous investigations, Webster, Syrotuik, Bell, Jones, & 
Hanstock, (2002) suggest HBO therapy is not an effective method of treatment for 
accelerating recovery following exercise-induced muscle damage. Strenuous eccentric 
exercise elicited muscle damage within the right gastrocnemius muscle. Subjects 
subsequently received either HBO (100% oxygen at 253 kPa [2.5 ATA] for 60 min; n = 6) 
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or sham (atmospheric air at 132 kPa [1.3 ATA] for 60 min; n = 6) treatment conditions. The 
first treatment was administered 3-4hr after damage, with a second and third at 24 and 48hr 
after the first, respectively. The results indicate there was little evidence of a difference in 
recovery rate between the HBO and sham groups although a faster recovery was observed 
in the HBO group for isometric peak torque and pain sensation and unpleasantness 
compared to the sham groups. Similarly Mekjavic, Exner, Tesch, & Eiken (2000) and 
Bennett, Best, Babul, Taunton, Lepawsky, & Bennett (2005) investigated the effects of 
HBO therapy on recovery after exercise-induced muscle injury. Over a 10 day recovery 
period, there was no difference in the rate of recovery of muscle strength between the two 
groups. Perceived soreness peaked at about 48hr after exercise with no difference between 
groups (Mekjavic et al, 2000). Bennett et al, (2005) showed there was some evidence that 
HBO therapy may increase interim pain in DOMS. However there was insufficient 
evidence from comparisons tested within randomised controlled trials to establish the 
effects of HBO therapy on soft tissue injury, or on experimentally induced DOMS. These 
results indicate that HBO therapy was not an effective therapy for the treatment of DOMS. 
Interestingly, the phagocytic and regenerative steps associated with muscle injury recovery 
may be dependant on the oxygen % and time of exposure to a HBO therapy. Similar to the 
previous study, Harrison, Robinson, Davison, Foley, Seda & Byrnes (2001) investigated 
the role of hyperbaric oxygen therapy in the treatment of exercise-induced muscle injury. 
The authors also concluded that the hyperbaric therapy was not effective in the treatment of 
exercise-induced muscle injury as indicated by the markers of isometric strength, rating of 
perceived soreness of the forearm flexors and creatine kinase. It is possible that a specific 
treatment may reduce muscle injury recovery and provide insight into the recovery process 
following EIMD after unaccustomed exercise.  
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There have been two mechanisms proposed whereby HBO may assist in the 
treatment of muscle injuries. The primary effect of HBO exposure is an increase in the 
oxygen content of arterial blood (PaO2) and a subsequent increase in the O2 diffusion 
gradient between the blood and tissue. A secondary effect may be a reduction in the 
inflammatory response due to a PO2-mediated vasoconstriction (Staples, Clement, Taunton, 
McKenzie, 1999). The timing of the HBO exposure may be of importance as the immediate 
post-injury administration would increase the potential oxygen diffusion gradient and 
reduce the inflammatory response (Harrison et al, 2001). However, it is still unclear 
whether or not there is significant soft tissue damage, and whether HBO therapy does 
reduce inflammation or just slow the process. It is possible that if the inflammatory process 
was over a longer time period it would cause necrosis and the subsequent tissue repair to be 
delayed.  The current research on the effect of HBO therapy on muscle damage recovery is 
inconclusive. However, research employing similar methods and design to the HBO 
therapy have not previously been used too investigate the effects of hypoxia on skeletal 
muscle regeneration.  
 
2.4 Air Travel 
Many aspects of the effects of mild hypoxia on human performance have been 
investigated since 1935, making significant contributions to flight safety (Armstrong, 1935; 
McFarland & Evans, 1939; Bryan & Leach, 1960; McFarland, 1971; Harding & Mills, 
1983).  Armstrong’s (1984) investigation of high-altitude flight included factors affecting 
tolerance of acute hypoxia, and oxygen toxicity, specifying the physiological requirements 
of sealed high-altitude aircraft compartments. The Royal Australian Air Force has 
recognized hypoxia as a significant physiological threat at altitude and have traditionally 
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trained aircrew to recognize the symptoms of hypoxia using hypobaric chamber training at 
simulated altitudes of 25,000 ft or more. Cable (2003) analyzed incidents of hypoxia 
reported to the Directorate of Flying Safety of the Australian Defence Force (DFS-ADF) 
for the period 1990-2001. The author found that twenty-seven reports of hypoxia involving 
twenty-nine aircrew were reported. In only two cases was consciousness lost, and one of 
these resulted in a fatality. Most incidents (85.1%) occurred in fighter or training aircraft 
with oxygen equipment routinely used with the majority of symptoms occurring between 
10,000 and 19,000 ft. The most common cause of hypoxia (63%) in these aircraft was the 
failure of the mask or regulator, or a mask leak. The symptoms were subtle and often 
involved cognitive impairment or light-headedness with the vast majority (75.8%) of these 
episodes recognized by the aircrew themselves. Therefore, useful planning maybe used to 
develop training strategies which reinforce the importance and benefit of hypoxia training 
in aviation physiology. Cable (2003) establishes the importance and effectiveness of the 
implementation of a hypoxic training program. Hypoxia incidents are most common at 
altitudes less than 19,000 ft therefore it should be emphasized that hypoxia is not only a 
problem of high altitude. Hypoxia in flight still remains a serious threat to all air travelers 
and can result in fatalities.  
This illustrates that aviation medicine was involved in arriving at the practical 
compromise with the often conflicting requirements of aircraft design (Ernsting, 1978). The 
cabins of virtually, all modern passenger aircraft are pressurized with air in order to prevent 
the occupants being exposed to low partial pressures of the environment at high altitude 
(Ernsting, 1978). Cabins are commonly pressurized to below 10,000ft and usually between 
5,000 and 7,000ft (Harding & Mills, 1983). The acceptance of mild hypoxia induced by 
breathing air at altitudes of up to 8,000ft (alveolar Pco2 of 40 mm Hg) is the correct 
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compromise for the allowable cabin altitudes of passenger aircraft (Ernsting, 1978). 
Respiration increases under the hypoxic drive, the symptoms and signs of hyperventilation 
develop with those of hypoxia. Hyperventilation is a normal response to a fall in alveolar 
PO2 to below 7.3-8.0 kPa (55-60 mm Hg) (Harding & Mills, 1983). Depending on the 
relationship between cabin and aircraft altitudes, it may be necessary to increase the 
concentrations of oxygen in the inspired gas above that which produces an alveolar PO2 of 
103 mm Hg (ambient air at sea level), in an attempt to prevent hypobaric hypoxia 
(Ernsting, 1978). The correct compromise is to provide a level of oxygen concentration in 
the inspired gas which maintains a sea level equivalent of inspired PO2 of 149 mm Hg, to 
inspired air at an altitude of 5,000ft, PO2 of 122 mm Hg. There appears to be advantages in 
maintaining the absolute pressure within the cabin at 1 atm during flight (Ernsting, 1978). 
However, the requirements to maintain absolute cabin pressure would reduce aircraft 
performance and its structure. The degree of pressurization increases linearly with, but at a 
slower rate than actual altitude, from ground level to a high maximum differential pressure 
(Harding & Mills, 1983). The greater the differential pressure of the environment at high 
altitude, the stronger and heavier the structure of the aircraft cabin needs to be (Ernsting, 
1978). Although medical authorities have accepted mild hypoxia as being a safe 
compromise for healthy individuals, the question of whether hypoxia exposure is 
detrimental to an injured athlete has not been answered.  
 
2.5 Eccentric Exercise-Induced Muscle Damage 
It is well-established that eccentric muscle actions induce muscle tissue damage, 
when the muscles are unaccustomed to the exercise (Armstrong, Warren, & Warren, 1990; 
Clarkson et al., 1992; Warren, Hayes, Lowe, & Armstrong, 1993; Hunter, & Faulkner, 
          26
1997; Ingalls, Warren, Williams, Ward, & Armstrong, 1998). Morphological changes are 
direct evidence of muscle damage (Friden, Sjostrom, & Ekblom 1983; Jones, Newham, 
Round, & Tolfree 1986). Indirect evidence such as the development of muscle soreness and 
swelling, decreases in force generation and range of motion, and elevated muscle protein 
levels (creatine kinase, myoglobin) in the blood demonstrate damage (Clarkson et al., 1992; 
Nosaka & Clarkson, 1996).  
Mechanical and metabolic mechanisms have been proposed for the initial events of 
EIMD (Armstrong et al., 1991). EIMD is assessed by measuring the efflux of specific 
cytosolic enzymes into the circulation, combined with histological techniques or 
ultrastructural examination. Muscle damage to small focal areas of the fibres has been 
observed immediately after exercise with the damage often becoming more extensive 48-
72hr post-exercise. Histological examination of the affected muscle shows myofibrillar 
disruption, increases in mitochondrial density and the content of cytoskeletal and 
myofibrillar proteins (Kuipers, Jannsen, Bosman, Frederik & Geurten, 1991). The increased 
concentration levels of cytosolic proteins in the circulation after exercise reflects muscle 
damage (Jones, Newham, Round & Tolfree, 1986). The most commonly studied protein is 
creatine kinase (CK), a protein normally detected in blood when muscle is damaged and 
caused by the leakiness of that muscle. Other muscle proteins such as lactate 
dehydrogenase, asparate aminotransferase, alanine aminotransferase, and myoglobin are 
also released into the blood and follow the same time course as CK (Nosaka, Clarkson, & 
Apple, 1992). The presence of these proteins and amino acids in the circulation reflects a 
significant alteration in the structure and permeability of the myofibrillar membrane (Jones 
et al., 1986).  CK is found exclusively in muscle tissue therefore most studies of EIMD 
have included its measurement.  
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The time course of the CK response has been studied following downhill running, 
marathon running and isometric exercise and usually peaks between 24-72hr post-exercise 
(Nuttal, Jones, 1968; Nosaka, Clarkson, & Apple, 1992; Clarkson et al., 1985). However, 
the amount of change and the time course of CK following these exercises is markedly 
different too that found following eccentric exercise (Clarkson, Nosaka, & Braun 1992). 
Byrnes et al. (1985) found the increase in CK activity in the blood to be substantially lower 
following downhill running compared with eccentric exercise of the elbow flexors. The 
changes in CK activity following downhill running are similar to the changes observed for 
isometric exercises (Clarkson, Apple, Byrnes, McCormick, & Triffletti, 1987; Clarkson, 
Litchfield, Graves, Kirwan, & Byrnes, 1985). Furthermore, the magnitude of muscle 
damage is also influenced by many factors, and responses to eccentric exercise are different 
between arm and leg muscle eccentric exercise. Tiidus & Ianuzzo (1983) reported that the 
intensity and duration of exercise affected serum enzyme activity and muscular soreness 
independently, with intensity having a greater effect.  
Why the various exercise models produce different results is not known. A possible 
explanation may be the extent of injury induced by the various regimes of exercise. 
Therefore, the larger increase in CK after high-force eccentric exercise compared with 
downhill running may be explained. However, Clarkson et al. (1992) suggest there is no 
explanation for the long delay before the rise in these proteins in the blood after high-force 
eccentric exercise. The blood levels of other muscle proteins (lactate dehydrogenase, 
asparate aminotransferase, alanine aminotransferase, and myoglobin) follow the same time 
course (Nosaka, Clarkson, & Apple, 1992). It is possible these proteins are not released by 
muscle fibers for at least 24hr, as Clarkson et al. (1992) suggested that the CK release from 
muscle following eccentric exercise may reflect necrosis of focal areas on the muscle 
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fibers. The eccentric exercise may initiate a series of events over a 48hr post-exercise 
period leading to focal necrosis. This series of events may involve an accumulation of 
calcium inside the cell, arising from damage to the membrane or to the sarcoplasmic 
reticulum (SR), activating cell degradation. 
An elevation in intracellular calcium ion (Ca2+) concentrations at the site of muscle 
damage indicates cellular necrosis and a loss of Ca2+ homeostasis. This elevation results in 
a decrement of muscle fibre performance (Armstrong et al., 1991). Ingalls et al., (1998) 
concluded that ‘the primary site for the excitation-contraction (E-C) coupling failure is the 
interface of the t-tubule and the SR Ca2+ release channel’. The reduced Ca2+ release and 
Ca2+ sensitivity account for the reduction in muscle force generating capacity (Balnave & 
Allen, 1995). Despite numerous studies having demonstrated eccentric EIMD, there is a 
conflicting consensus as to the actual mechanism. In general, the most convincing evidence 
supports mechanical factors rather than metabolic factors responsible for the initiation of 
muscle damage (Warren et al., 1993; Armstrong, et al., 1991).  Mechanical factors such as 
sacromere length (Hunter, & Faulkner, 1997; Jones, Newham, & Torgan, 1989) strain, 
(Brooks, Zerba, & Faulkner, 1995; McCully & Faulkner, 1985, 1986) velocity (Morgan, 
1990) total work (Lieber, Woodburn, & Friden, 1991) and force (Brooks, Zerba, & 
Faulkner, 1995) during eccentric contractions have been proposed as factors determining 
the level of EIMD. The initial exposure and magnitude of an eccentric contraction, 
including the individual reaction, may influence the amount of muscle tissue damage and 
any further damage as a result of multiple trials.  
Eccentric EIMD causes delayed-onset muscle soreness (DOMS) as a result of 
muscle fibre damage. DOMS usually occurs from 1–5 days following unaccustomed 
exercise, reducing muscular performance by a voluntary reduction of effort and/or from the 
          29
muscle’s inability to produce force(s). The reduction in performance is temporary and 
without any permanent impairment.  Clarkson, Nosaka, & Braun (1992) measured 
variables, maximal strength and the ability to flex the arm, following eccentric exercise and 
showed the greatest decrements immediately following the exercise, to three days after 
exercise with a linear restoration of these functions over the next ten days.  However, the 
decrements may be relative to the muscle type damaged. The quadriceps muscles of the leg 
may not damage similarly to the biceps muscles of the arm as there is less mass and 
possibly more or less fast/slow twitch fibres in that particular muscle investigated. 
Therefore, the information presented must be met with caution when analyzing data.  
 
2.5.1 Creatine Kinase Activity 
Increased levels of muscle proteins in the blood have routinely been used to 
diagnose muscle damage (Byrnes et al., 1985; Clarkson, & Tremblay, 1988; Ebbling, & 
Clarkson, 1990). The most commonly studied protein is creatine kinase (CK), a protein 
normally detected in blood when muscle is damaged and caused by the leakiness of that 
muscle. The time course of the CK response has been studied following downhill running, 
marathon running and isometric exercise. However, the amount of change and the time 
course of CK following these exercises is markedly different to that found following 
eccentric exercise (Clarkson, Nosaka, & Braun 1992). Byrnes et al., (1985) found the 
increase in CK activity in the blood to be substantially lower following downhill running 
compared with eccentric exercise of the elbow flexors. The changes in CK activity 
following downhill running are similar to the changes observed for isometric exercises 
(Clarkson, Apple, Byrnes, McCormick, & Triffletti, 1987; Clarkson, Litchfield, Graves, 
Kirwan, & Byrnes, 1985). 
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Why the various exercise models produce different results is not known. A possible 
explanation may be the extent of injury induced by the various regimes of exercise. 
Therefore, the larger increase in CK after high-force eccentric exercise compared with 
downhill running may be explained. However, Clarkson, Nosaka, & Braun (1992) suggest 
there is no explanation for the long delay before the rise in these proteins in the blood after 
high-force eccentric exercise. The blood levels of other muscle proteins (lactate 
dehydrogenase, asparate aminotransferase, alanine aminotransferase, and myoglobin) 
follow the same time course (Nosaka, Clarkson, & Apple, 1992). It is possible these 
proteins are not released by muscle fibers for at least 24hr, as Clarkson, Nosaka, & Braun 
(1992) suggested that CK release from muscle following eccentric exercise may reflect 
necrosis of focal areas on the muscle fibers. The eccentric exercise may initiate a series of 
events over a 48hr post-exercise period leading to focal necrosis. This series of events may 
involve an accumulation of calcium inside the cell, arising from damage to the membrane 
or to the sarcoplasmic reticulum (SR), activating cell degradation. 
 
2.6 Exercise-Induced Muscle Damage Recovery  
Previous studies have shown that various forms of eccentric EIMD, although the 
damage mechanism and repair are unclear. Hurley (1983) suggested chemical, thermal or 
mechanical stimuli may be a mechanism responsible for muscle damage. The two 
mechanisms proposed in an effort to explain muscle damage following exercise are 
mechanical stress and metabolic stress. Mechanical stress has been proposed as being 
responsible for muscle damage as a direct result of the mechanical shear forces produced 
during exercise, whilst metabolic stress is characterized by disturbances in normal cellular 
metabolism caused by unaccustomed endurance exercise (Ebbeling, & Clarkson, 1989; 
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Armstrong, Warren, & Warren, 1991). It is possible that both mechanisms may be involved 
in initiating a sequence of inflammatory and immunological events leading to reversible 
damage to muscle fibres (Appell, Soares, & Duarte, 1992), removal of damaged tissue, 
promotion of growth, repair and restoration of normal physiological function (Armstrong, 
Warren, & Warren, 1991).  
The process of inflammation also involves a vascular and cellular response. The 
vascular response causes an initial vasoconstriction for approximately 5-10min, followed 
several hours later by a period of vasodilation and increased vascular permeability (Ryan, 
& Majno, 1977). The cellular phase of inflammation involves two types of white blood 
cells, neutrophils and monocytes. Within a few hours following muscle damage there is an 
increase in the number of circulating neutrophils and monocytes, where the cells begin to 
migrate at the site of disruption. Monocyte migration begins several hours after neutrophil 
migration with the concentration at the site of injury rising steadily where it is maintained 
for 48 hours. When the monocytes leave the blood and enter the tissue compartment, they 
mature into adult macrophages. Their primary purpose is to dispose of necrotic tissue and 
remove foreign bodies (Peacock, 1984. pp. 1-14). 
Several studies have investigated the use of therapies or treatments to restore injured 
athletes to full recovery (Harrison, Robinson, Davison, Foley, Seda, & Byrnes, 2001; 
Strauss, Hargens, Gershuni, Hart, & Akeson, 1986; Tiidus, 1997; Rodenburg, Bar, & De 
Boer, 1993). However, there are conflicting results regarding treatment efficacy for these 
related injuries. These studies have been limited by subject availability and study designs 
characterized by the precise control of variables; degree of injury, type of injury and timing 
of initial treatment. 
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At the elite level of competition the treatment of soft tissue injuries are frequently treated 
with the use of hypobaric oxygen. Hyperbaric oxygen therapy is the breathing of 100% 
oxygen in a treatment chamber at 2-3 atmospheres absolute pressure (Harrison, Robinson, 
Davison, Foley, Seda, & Byrnes, 2001). Although, the hemoglobin is 97% saturated by 
ambient air, breathing 100% oxygen increases the hemoglobin-oxygen saturation by 3% 
whilst the remaining oxygen is dissolved in the plasma. However, there is always a waste 
of approximately 5% oxygen when inspiration occurs, so the question of whether breathing 
100% oxygen is of benefit has not been answered to date. Therefore, is breathing 100% 
oxygen an expensive luxury for those who can afford it and is it ethical if not everyone is 
able to afford it? It is suggested more research including ethical behaviour is required into 
HBO therapy for muscle damage recovery.   
Following a high impact injury, Nylander, Lewis, Nordstrom, et al., (1985) and 
Nylander, Nordstrom, Lewis et al., (1987) established that ATP in postischemic muscle 
was preserved with a 50% reduction of edema following a hyperbaric treatment. 
Hyperbaric oxygen supposedly improves environment conditions for damaged muscles, 
tendons and ligaments. Presently, the benefit(s) associated with hyperbaric oxygen 
treatment, as a very expensive therapy modality of soft tissue injuries, remains unproven 
whilst the risks; such as tympanic membrane perforation are significant. Currently, the 
scientific evidence suggesting the use of hyperbaric oxygen in the treatment of soft tissue 
injury remains inconclusive. 
 
2.8 Summary 
The lack of literature on the effect of hypoxia on muscle damage suggest that 
recovery procedures which incorporate strategies for continued recovery post game and 
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training regimes need to be investigated so that training recovery procedures during travel 
will assist in providing adequate recovery of damaged muscle tissue in time for the next 
training session and for the following competition. 
The investigators of the present study hypothesized hypoxia experienced during 
short-term air travel may delay exercise-induced muscle damage recovery. Muscle damage 
recovery following short-term (4hr) exposure to normobaric hypoxia after eccentric EIMD 
has not been previously investigated, therefore, the investigators of the present study 
believe research into the effects of short-term (4hr) normobaric hypoxia following muscle 
damage is valuable. 
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CHAPTER THREE     
 
METHODOLOGY 
 
Previous studies investigating the phenomena of exercise-induced muscle damage 
have shown measures of increased plasma CK, soreness, tenderness and prolonged loss of 
muscle function to be common indicators of muscle damage (Clarkson, & Tremblay, 1988; 
Byrnes et al., 1985; Sargeant, & Dolan 1987, Edwards, Mills & Newham, 1981; Eston, 
Finney, Baker, & Baltzopoulos, 1996). Previous studies (Nosaka, & Sakamoto, 2001; 
Schwane, Johnson, Vandenakker, & Armstrong, 1983a, Clarkson, Byrnes, Gillisson, & 
Harper, 1987) have shown eccentric muscle actions induce muscle damage. The present 
study’s knee extensor exercise model was designed using the previous studies protocols as 
the knee extensor muscles are involved in most exercise activities. 
 
3.1 Ethical Considerations 
Ethical approval was granted by Edith Cowan University Ethical Committee and 
guidelines outlined by the University dated February 1998 were adhered to. Subjects gave 
their informed consent (Appendix A), and were free to withdraw their participation at any 
time of the investigation. Data handling was carried out by the primary investigator and 
secured in a filling cabinet and personal computer. 
 
3.2 Subjects 
The subject cohort for this investigation included sixteen male subjects aged 18-34 
(mean + SD) 21.9 + 5.2 years, height 176.2 + 8.8 cm and body mass 73.7 + 8.2 kg (see 
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Table 1). Although the sample size in the present study is small, the number of subjects is 
similar to previously mentioned studies therefore allows for comparisons. Each subject 
signed a informed consent form (Appendix A) and completed an extensive medical history 
questionnaire (Appendix B), after being advised of the purposes of the investigation and 
methodology of tests. Subjects were randomly assigned to either a control (CON or 
normoxia) and hypoxic (H) groups (see Table 1). Although there is a significant difference 
between H and N group’s ages there was no significant difference between the H and N 
group’s pre-EIMD measured variables. Subject identification numbers were allocated and 
used to ensure confidentiality. Subjects had not been involved in eccentrically based 
conditioning or strength training of the lower limb in the 6 months prior to the investigation 
and reported not having any previous history of lower limb injury and were free from 
muscle soreness/tenderness. Subjects were informed they were able to participate in their 
normal daily activity, but were requested to refrain from taking anti-inflammatory 
medicines and/or similar medications.  
Table 1         
Subject characteristics       
Hypoxic Group Normoxic Group 
         
Subject Age  Height  Body Mass  Subject Age  Height  Body Mass  
  (yr) (cm) (kg)     (yr) (cm) (kg) 
H1 25 168.20 67.20  N1 19 176.50 76.80 
H2 31 180.60 79.20  N2 18 180.00 79.50 
H3 21 176.00 69.00  N3 19 187.00 81.90 
H4 30 164.00 73.00  N4 22 179.00 71.00 
H5 34 167.50 74.00  N5 21 175.00 75.70 
H6 18 174.00 72.00  N6 18 160.50 59.30 
H7 18 190.50 79.00  N7 18 168.00 61.00 
H8 19 183.50 68.00   N8 20 188.00 92.50 
Mean 25.29 174.40 73.34   19.29 175.14 72.17 
SD 6.44 9.00 4.63   1.51 9.19 10.93 
SEM 2.28 3.18 1.64   0.53 3.25 3.86 
SED 2.34 4.55 4.19      
t test 0.04 0.80 0.69           
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3.3 Testing Procedures 
3.3.1 Testing Schedule 
Each subject was tested over a 10-day period (Table 2) with testing protocols 
identical for the H and N groups. Subjects were randomly assigned into a H or N group.  
As the test-retest results showed no significant difference between groups, testing 
immediately after the eccentric EIMD protocol was not included as previous studies have 
established 24-48hr post exercise is the period of maximal soreness and tenderness. 
Furthermore, the number of variables measured, and the H and N 4hr treatment following 
EIMD made it impractical to measure variables immediately after EIMD. However, it is 
noted that testing immediately following eccentric EIMD may be important to establish no 
significant differences between conditions at this time point. 
Table 2. 
Outline of the testing protocol over the 10-day period.
Day -4 -3 -2 -1 0 1 2 3 4 5 
Stage  Pre-test   EIMD   Post-test   
           
Test 
Number 
1  2  3 4 5 6 7 8 
           
Variables 1. Anthropometry 1.  Warm up & stretch Test 1 variables 2 – 8 
 Height (cm), Body mass (kg) 2.  Eccentric EIMD protocol Post – test time 
 2. Creatine kinase activity 3.  Cool down & stretch 24, 48, 72, 96, 120hr 
 3. Soreness 4.  Normobaric hypoxia    
 4. Tenderness      exposure (test group)  
 5. Isometric max strength 5.  Normobaric normoxia      
 6. Isokinetic peak torque      (control group)      
 7. Vertical jump height       
 8. Eccentric leg strength       
 
EIMD = Eccentric exercise induced muscle damage 
 
The results for Tests 1 & 2, isometric strength, isokinetic peak torque and vertical 
jump for all subjects were used for determining the reliability of the testing protocols. Both 
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H and N groups performed the same series of tests. The N group was exposed to four-hours 
of normobaric hypoxia, while subjects in the H group experienced a four-hour normobaric 
normoxia condition following the eccentric EIMD protocol on the third testing session (day 
five). Baseline measures used for comparisons across time were taken from the subject’s 
highest peak values recorded during either Test 1 or Test 2. Measurements taken during the 
various test days are shown in Table 3.   
Table 3. 
Testing sessions and variables measured 
            Testing Variables 
Test 1 & 2                        Test 3 Tests 4 – 8 
  1. Anthropometry 1.  Warm up & stretch Test 1 variables 2 – 8  
      Height (cm), Body mass (kg) 2.  Eccentric EIMD protocol Post – test time 
  2. Creatine kinase activity 3.  Cool down & stretch 24, 48, 72, 96, 120hr 
  3. Soreness 4.  Normobaric hypoxia exposure  
  4. Tenderness (test group)   
  5. Isometric max strength 5.  Normobaric normoxia   
  6. Isokinetic peak torque (control group)  
  7. Vertical jump height    
  8. Eccentric leg strength          
 
 
3.4 Testing Protocols 
3.4.1 Warm-up 
Subjects completed a six-minute intermittent warm up on a Repco cycle ergometer 
(RE7000, Australia) at intensities comfortable to the individual subject followed by 
stretching of the quadriceps, hamstrings and calf muscles of both lower limbs. Subjects 
were permitted a 2-minute preparation period to re-hydrate, adjust their clothing or visit the 
bathroom before performing the EIMD (knee extensor) protocol.  
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3.4.2 Eccentric Exercise Induced Muscle Damage Protocol 
An intermittent eccentric contraction of the knee extensor muscle group (described 
by Tiidus & Ianuzzo, 1983) was used to induce muscle damage of the quadricep muscles 
for the H and control groups using a Cybex 6000 dynamometer (Cybex division of Lumex, 
Ronkonkoma, New York).    
Subject’s performed 60 (10 reps x 6 sets) eccentric contractions of the knee 
extensors of the dominant (preferred) leg at the angle from 0O (fully extended position) to 
90O (fully flexed position). Muscle contractions were performed at a rate of 9O.s-1 to 
maximize the damage effect, controlled by Cybex 6000 isokinetic dynamometer (Cybex 
division of Lumex, Ronkonkoma, New York), with a 20s inter-trial rest. Each of the six 
sets was separated by a 2 minute rest period for maximal repeat efforts. The exercising limb 
was returned to the fully extended position at a rate of 9o.s-1 by the Cybex 6000 isokinetic 
dynamometer. The subject begins the exercise with the leg fully flexed (90o). The 
investigator initiates the exercise using the computer system attached to the apparatus. The 
mechanical lever system then extends the limb to the fully extended position (0o). The 
subject then starts the apparatus by contracting the quadriceps muscles. The mechanical 
advantage of the computer lever system is that it provides maximal resistance to the subject 
throughout the entire range of motion. Each of the six sets was separated by a 2 minute rest 
period. This allowed the subject to perform a series of maximal effort eccentric actions. 
Subjects were seated upright and stabilized using a lap sash seat belt around the trunk and 
pelvis, including a thigh strap securing the exercised limb. Subjects were required to fold 
their arms across their chest minimizing extraneous body motion and the effect of 
accessory muscle groups. Subjects received verbal encouragement throughout each trial.  
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3.4.3 Normobaric Hypoxia Protocol  
The normobaric hypoxia protocol was performed exactly two hours after the 
eccentric EIMD and consisted of a four-hour treatment of breathing a medical grade gas, 
consisting of 15.37% O2 and 84.63% N2, in an isolated room with equipment (chairs set up 
in rows with small tables, a television and video, music and magazines) similar to that 
present within a passenger aircraft. Each subject wore a mask attached to an oxygen 
cylinder (tissot tank) with a flow rate of 5ml per minute. Humidity, barometric pressure and 
temperature were maintained and recorded.  
  
3.4.4 Normobaric Normoxia Protocol 
The normobaric normoxia protocol was performed exactly two hours after the 
eccentric EIMD and consisted of a four-hour (similar time frame for normobaric hypoxia 
protocol) breathing ambient air, in an isolated room with equipment (chairs set up in rows 
with small tables, a television and video, music and magazines) similar to that within a 
passenger aircraft. Subjects wore a mask attached to an oxygen cylinder (tissot tank) with a 
flow rate of 5ml per minute. Each subject was required to follow exactly the same protocols 
as the normobaric hypoxia condition, controlled by the investigator. Humidity, barometric 
pressure and temperature were maintained and recorded.  
 
3.5 Testing Measures 
3.5.1 Height  
Subject’s height was measured using height scales - Seca 220 whilst standing in the 
anatomical position with bare feet and heels together.  
3.5.2 Body Mass 
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Subject’s body mass was measured to the nearest 0.05kg using electronic scales – 
Mettler ID 1 MultiRange wearing underwear and bare feet.  
 
3.6 Creatine Kinase (CK) Activity 
 A single blood sample, collection of 30 µL blood, from a finger prick sample from 
each subject was analyzed pre EIMD, immediately following the eccentric EIMD and 24, 
48, 72, 96 and 120hr post eccentric EIMD using a Reflotron analyzer (Boehringer-
Manheim, Pode, Czch Republic) to determine plasma creatine kinase (CK) activity. The 
normal reference range for CK activity using this method is 50-220 IU.L-1 according to the 
information provided by the spectrophotometer company.  
 
3.7 Muscle Soreness  
Measurements of quadriceps (Rectus femoris, Sartorius, Vastus & Vastus lateralis) 
muscular soreness was assessed using a scale of 1-10 (see Appendix C), where 1 = no 
soreness and 10 = very sore (Clarkson & Tremblay, 1988) at baseline, 24, 48, 72, 96, and 
120hr post eccentric EIMD protocol. Subjects were required to walk 10 meters, in a straight 
line and assign a score of 1-10 when asked “how would you rate the level of pain you 
experienced in the quadriceps of the exercised leg normal (1), somewhat sore (3), 
moderately sore (5), very sore (8) or very, very sore (10)”?. The mean values for each 
subject’s total soreness were used for statistical analysis.  
 
3.8 Muscle Tenderness 
Muscle tenderness evaluations were conducted on the quadriceps muscle group 
using a dobros myometer, with a maximum value of 100kp, at baseline and at 24, 48, 72, 
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96, and 120hr post eccentric EIMD. The myometer was placed on the muscle (Rectus 
femoris: located the anterior-inferior spine of the ilium and the top of the patella and 
patellar ligament to the tibial tuberosity, the point of measure was at the mid point on a 
straight line between the origin and insertion. Sartorius: located the notch between the 
anterior-superior and anterior-inferior spines of the ilium and the anterior medial condyle of 
the tibia, the point of measure was at the mid point on a straight line between the origin and 
insertion. Vastus lateralis: located the outer surface of the femur below the greater 
trochanter and upper half of the linea aspera and the outer half of the upper border of the 
patella and the patellar ligament to the tibial tuberosity, the point of measure was at the mid 
point on a straight line between the origin and insertion. Vastus: located the inner half of 
the upper boarder of the patella and patellar ligament to the tibial tuberosity, the point of 
measure was 10cm superiorly from the insertion along the linea aspera and internal 
condyloid ridge.), applying downward pressure until the subject indicated discomfort; a 
measure was then obtained from the myometer pressure gauge and recorded.  
 
 Rectus femoris  Sartorius 
 Vastus lateralis 
 Vastus 
Figure 1 Quadriceps muscle group. 
Markers indicate sites used for assessing tenderness. 
 
Adapted from: Thompsom, C.W., (1985). Manual of structural kinesiology. (10th ed.).  
St.Louis: Times Mirror/Mosby. 
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3.9 Maximal Isometric Strength 
Maximal isometric strength was determined using a Cybex 6000 Isokinetic 
Dynamometer (Cybex division of Lumex, Ronkonkoma, New York). Subjects were seated 
with the backrest at an angle of 1250 and stabilized using a lap sash seat belt around the 
trunk and pelvis and a velcro strap around the thigh of the exercised limb. Subjects were 
required to fold their arms across their chest to minimize extraneous body motion and the 
effect of accessory muscle groups.  
Subjects performed 3 maximal isometric voluntary contractions (MVC) involving 
the quadriceps muscle group (knee extensors) of the test limb. The axis of the dynamometer 
was aligned with the transverse axis of the knee joint with a shin pad placed 2.5 cm 
proximal to the medial malleoli. Gravitational effect on torque (GET) was determined for 
each subject and added to the knee extensor measure. The test protocol consisted of 2 x 10s 
maximal voluntary contractions (MVC) at 75O, 55O & 35O of the knee extensors to assess 
recovery from one test to the second test. Tiidus & Ianuzzo (1983) reported the intensity 
and duration of exercise affected serum enzyme activity and muscular soreness 
independently, with intensity having the more pronounced effect therefore, 10’s isometric 
model was used to increase the intensity and likelihood of muscle damage markers. Sixty 
seconds rest was permitted between the 2 test repetitions with 2 minutes rest between each 
test angle. The highest value measured for each set of 3 MVC was recorded as maximal 
strength (Nm). Subjects received verbal encouragement throughout the test.  
 
3.10 Maximal Isokinetic Concentric Strength 
Isokinetic peak torque was measured using a Cybex 6000 Isokinetic Dynamometer. 
Subjects performed 3 maximal concentric contractions involving the quadricep, hamstring 
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and gluteal muscle groups of the test limb, range of motion (ROM) from 90o to 0o  (neutral) 
of knee extension/flexion at a velocity of 60, 120 and 240o.s-1. The axis of the dynamometer 
was aligned with the transverse axis of the knee joint with a shin pad placed 2.5 cm 
proximal to the medial malleoli. GET was determined for each subject and added to the 
knee extensor measure. The test protocol consisted of one sub-maximal practice repetition, 
followed by 3 MVCs of the knee extensors. Twenty seconds rest was permitted between 
each contraction. Each subject received verbal encouragement with the highest value of the 
3 MVCs recorded as maximal isokinetic strength (Nm).  
 
3.11 Squat Jump   
Subjects muscle function followed protocols used by MacDougall, Wenger, and 
Green (1991, p64) using a TMFsports vertical jump tester. Subject’s squat (or static) jump 
(SJ) height was measured as the difference between standing height and maximal height 
attained in a SJ. Subjects performed 3 single leg vertical jumps on their dominant limb with 
1min rest between each repetition with the greatest height of the three measures recorded. 
The subject began the test in a crouched position with the hip and knee joints at a 90O angle 
the subject was instructed to place their elbows to the side of their body, arms in a vertical 
position, hands in a position so that the fingers were at eye level. Following take off the 
subject’s dominant arm extended to touch the vertical height indicator straps.     
 
3.12 Statistical Analysis 
Test-retest data for the coefficient of variation of method error and correlation of the 
coefficient for isometric strength, isometric torque and vertical jump height were 
determined from the two baseline tests (see Table 4). Each dependant variable was 
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analyzed using a 2 x 6 (group x time) repeated measure of analysis of variance (ANOVA), 
with significance set at p<.05. Significant differences found in the ANOVA were further 
analyzed using a SPSS statistical analysis program, Bonferroni adjustment. All results are 
reported as the mean (+ SEM) with raw and normalized data presented in Appendix D. 
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CHAPTER FOUR     
 
RESULTS 
 
4.1 Reliability 
Data for the coefficient of variation of method error (CV) and correlation of the 
coefficient (r) for test-retest variables; isometric strength (350, 550 & 750 of knee flexion), 
isometric torque (60, 120 & 240 deg/s) and vertical jump height are presented in Table 4. 
Reliability for the testing variables was good as all test-retest variables have a coefficient of 
variation below 5%, indicating no systematic change between the two tests. The correlation 
coefficient (R) for test-retest measures of isometric strength, isokinetic torque and vertical 
jump were 0.96, 0.94 and 0.88 respectively.   
 
 
Table 4. 
Coefficient of variation of method error for testing variables 
  
   Coefficient of Variation (CV) and Correlation of Coefficient (r) 
                         
               Hypoxic (H) Group             Normoxic (CON) Group           
       Test Variables                         
_________________________________________________________________________ 
 
Isometric Strength         angle                CV (%)     r                         CV (%)      r 
        
     35             2.36      0.98            3.55       0.94 
     55    3.52     0.95            5.42 0.87  
     75    4.07    0.97            4.32 0.95 
Isokinetic Torque                   deg/s 
                      60       2.44    0.98            2.51 0.98 
120       4.61    0.93            3.68 0.97 
240    4.31    0.96            4.54 0.98 
 
Vertical Jump       7.93    0.81            3.01 0.95 
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4.2 Extensor Isometric Strength  
 Isometric strength measures at 35O, 55O and 75O are presented in Figures 2-5. A 
significantly greater strength increment at the angle 35O was recorded from baseline to 
120hr for the N group (p<0.05; Figure 2) compared to no significant difference between 
baseline to 120hr for H group. Figure 5 shows, extensor isometric strength at 35O, a 
significant difference between the H and N groups at 48hr (p<0.05). H group isometric 
strength at 35O decreased from baseline measures by 6% at 24hr then increased by 14% at 
120hr compared to the N group isometric strength increase from baseline by 7% and 20% 
respectively. The testing bouts over time and the treatment by time interaction were 
statistically significant for both groups (p<0.05).  
 At 55O the H and N group showed no significant difference across time although 
strength was elevated at 120hr compared to baseline. The H group showed a decline in 
strength at 24hr post-EIMD compared to the N group small increase (Figure 3). Isometric 
strength at 55O showed a significant difference (p<0.05) between the H and N groups 
percentage change at 72hr post-EIMD. No significant differences were recorded for 
isometric strength between the H and the N group at the angle 55O at any of the 
measurement times (Figure 3). However, mean isometric strength at 55O for the H group 
decreased by 7% from baseline to 24hr post-EIMD compared to the N group, which 
increased by 5% from baseline to 24hr.  
Following EIMD both the H and N group failed to show any decrement in strength 
(Figure 5). Isometric strength at 75O showed no significant differences between the H and N 
groups at any of the measurement times (Figure 5). N group’s isometric strength increased 
by 15% at 72hr, 20% at 96hr and 30% at 120hr post-EIMD compared to baseline measure. 
Whilst H group’s isometric strength increased by 14% at 72hr, 7% at 96hr and 25% at 
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120hr compared to baseline. Although not significant, the overall pattern of increase in the 
isometric strength over time was greater for the N group compared to the H group. 
However, the H group shows a linear increase in strength across time whereas the N group 
shows incremental increases in strength from 24-48hr and 96-120hr.  
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Figure 2. Extensor isometric strength (35 deg) across time for Hypoxia group  
               (n=8) and Normoxia group (n=8). *Significant difference between H and N groups at 48hr  
                  (p < 0 .05). 
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Figure 3. Extensor isometric strength (55 deg) across time for Hypoxia group  
                 (n=8) and Normoxia group (n=8). 
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Figure 4. Extensor isometric strength (75 deg) across time for Hypoxia group  
               (n=8) and Normoxia group (n=8). 
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4.3 Extensor Isokinetic Torque   
 
Isokinetic torque at 60O-sec was not significantly different between the H and N 
groups (Figure 5). Post-EIMD Isokinetic 600-sec torque for the N group increased 
progressively, peaking (13.3% greater than baseline) at 120hr. In comparison, H group 600-
sec torque decreased progressively between baseline and 96hr post-EIMD, then peaked (7% 
greater than baseline) at 120hr. Figure 5 shows there was no significant group by time 
interaction effect for the N or H groups.  
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Figure 5. Extensor isokinetic torque (Nm) at 60 deg/sec across time for  
                 Hypoxia group (n=8) and Normoxia group (n=8). 
 
 
 
          50
Isokinetic torque at 120O-sec was not significantly different between the H and N 
groups (Figure 6). Isokinetic torque for the N group was shown to increase by 3% (24hr) 
and 10% (120hr). However, a decrease of 7% (24hr) and increases of 16% (48hr) and 6% 
(120hr) were observed for the H group. There was no significant group by time interaction 
effect for the N or H groups.  
0
50
100
150
200
250
0 24 48 72 96 120
Time (hours)
To
rq
ue
 (N
m
)
Hypoxia Group
Normoxia Group
pre
EIMD
 
Figure 6. Extensor isokinetic torque (Nm) at 120 deg/sec across time for  
                 Hypoxia group (n=8) and Normoxia group (n=8). 
 
 
Isokinetic torque at 240O-sec was not significantly different between the N and H 
groups (Figure 7). Isokinetic torque at 240O-sec increased by 16% (48hr) and 14% (120hr) 
for the N group, while the H group increased by 4% (48hr) and 5% (120hr). The results 
show there was no overall significant group by time interaction effect for both N and H 
groups.  
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Figure 7. Extensor isokinetic torque (Nm) at 240 deg/sec across time for  
                 Hypoxia group (n=8) and Normoxia group (n=8). 
 
 
 
4.4 Vertical Jump (VJ) 
 
Squat jump (SJ), presented in Figure 10 showed that there was not a significant 
difference between the groups at any of the measurement times following EIMD, although 
SJ levels in the N group was greater than the H group. H group’s SJ values decreased by 
6% at 24hr post-EIMD in comparison to the N group’s decrease of 3% respectively.  
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Figure 8. Vertical jump across time for the Hypoxia group (n=8) and Normoxia group  
     (n=8). 
 
 
4.5  Plasma Creatine Kinase Activity 
 
Plasma creatine kinase (CK) activity is presented in Figure 9. Plasma CK was 
significantly greater (p<0.05) for the N and H groups at 24-96hr and 96-120hr respectively 
after EIMD compared to baseline measures, then gradually recovered. However, plasma 
CK was still elevated at 120hr after EIMD for both groups. Plasma CK activity was not 
significantly different between the H and N groups, although significantly larger increases 
in CK following EIMD were found between baseline measures and post-EIMD times for 
both groups (p<0.05). Plasma CK activity for both N and H groups peaked at 48hr and 
96hr post-EIMD, respectively.  
          53
0100
200
300
400
0 24 48 72 96 120
Time (hours)
Pl
as
m
a 
CK
 A
ct
iv
ity
 (I
U
/L
)
Hypoxia Group
Normoxia Group
* *
*
*
pre
EIMD
*
 
Figure 9. Plasma creatine kinase (CK) activity across time for the Hypoxia (n=8) and  
   Normoxia groups (n=8). *Plasma CK activity levels were significantly (p< 0.05) elevated    
    post- eccentric EIMD compared to baseline (0hr) at 24-96hr for N group and 96-120hr for H   
    group.   
  
 
 
4.6 Muscle Tenderness  
 
Figure 10 shows H group tenderness declined from baseline to 48hr post-EIMD, 
then increased from 48hr to 72-96hr, where tenderness returned close to baseline levels at 
120hr. N group tenderness also declined, similar to H group, from baseline to 24hr post-
EIMD, however N group tenderness recovered from 24-96hr, returning close to baseline 
levels at 120hr. Muscle tenderness for both groups showed a similar recovery trend across 
time. Muscle tenderness during palpation was not significantly different between the H and 
N groups across time. Although not significantly different, muscle tenderness was greater 
for the H group compared to that of the N group at 48hr -120hr post-EIMD. Although not 
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significantly different, Figure 10 shows somewhat of a delay in recovery from muscle 
tenderness for the H group for all post-EIMD times compared to the N group.   
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Figure 10. Mean tenderness across time for Hypoxia group (n=8) and Normoxia  
     group (n=8). 
 
 
4.7 Muscle Soreness  
Figure 11 shows muscle soreness was significantly (p<0.05) different to baseline 
measures for the N and H groups at 24hr after EIMD. Muscle soreness peaked at 24hr post-
EIMD in both the H and N groups, whilst both groups showed a similar trend across time. 
Muscle soreness recovery for the H group was delayed between 24-96hr compared to the N 
group delay between 24-72hr post-EIMD, whilst both groups returned to normal by 120hr 
post-EIMD. A significant difference was recorded between the H and N groups at 24hr 
post-EIMD (p<0.05) for muscle soreness. Although not significant, soreness was greater in 
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the H group compared with the N group at time point’s 48-120hr post-EIMD. Perceived 
muscle soreness between the H and N groups showed an interaction between treatment and 
post-EIMD time (p<0.05).  
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Figure 11. Mean soreness across time for Hypoxia group (n=8) and Normoxia  
               group (n=8). * Significant (p < 0.05) difference between H and N groups at 24hr.  
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CHAPTER FIVE     
 
DISCUSSION 
                                                                                
The present study found that isometric strength at 35O was significantly different 
between the H and N groups at 48hr post-EIMD (p<0.05). Isokinetic torque (60O-sec, 120O-
sec and 240O-sec) results show there was no overall significant effect across time between the 
N and H groups. SJ showed that there was no significant difference between the groups at 
any of the measurement times, although SJ levels in the N group were greater compared to 
the H group.  Plasma CK activity peaked at 48hr (N) and 96hr (H) post-EIMD. Plasma CK 
significantly increased (p<0.05) at 24hr after EIMD for both groups, this increase was 
sustained for the next 24-96hr, then started to gradually recover however, plasma CK was 
still elevated at 120hr after EIMD. Muscle tenderness, although not significantly different, 
was greater for the H group compared to that of the N group at 48hr -120hr post-EIMD, 
both groups showed a similar recovery trend across time. Muscle soreness peaked at 24hr 
post-EIMD in both the H and N groups, a significant difference was observed between the 
H and N groups at 24hr post-EIMD (p<0.05).  
The purpose of the present study was to investigate the effects of a short-term (4hr) 
normobaric hypoxia insult on eccentric-EIMD recovery. Although previous studies 
(Ernsting & Sharp, 1978; Robergs, Quintana, Parker, & Frankel, 1998) have investigated 
hypoxia, to the author’s knowledge, the effects of hypoxia on EIMD recovery has not been 
previously investigated. Anecdotal evidence suggests that exposure to a hypoxia insult 
would retard recovery from EIMD. A group of elite athletes who travel by air for a short 
time, west to east (3.5hr) for competition and return east to west (4hr) 2hr following 
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competition reported feeling lethargic, muscle soreness and tenderness and a loss of 
strength for a period of up to 72-96hr following the air-travel after competition compared to 
feelings of normality at 24-48hr when there was no air-travel after competition. The 
athletes wanted to know if the effects were a result of the physical, both internal and 
external, impact of competition the travel or a combination of a number of unknown 
factors. It was hypothesized that the recovery of isometric muscular strength, isokinetic 
peak torque, vertical jump, muscle soreness, muscle tenderness, and plasma CK activity 
would be significantly slower for the H group than the N group. However, the results 
showed there was not a significant difference between the H and N groups following 
EIMD. The results suggest that a 4hr hypoxia treatment after EIMD did not exacerbate 
muscle damage or slow the repair process.  
 
5.1 Isokinetic Torque & Isometric Strength   
The hypothesis that a hypoxic insult will delay muscle damage recovery was not 
supported by the isometric and isokinetic muscle tests. Although the N group was able to 
produce greater isometric strength and isokinetic torque measures and total work compared 
to the H group, this was to be expected seeing that the N group presented a marginally 
larger mass than the H group, and therefore likely possessed a greater lean muscle mass 
than the H group. Furthermore, H group was significantly older (yr) than the N group 
which suggests a potential for greater strength to be produced compared to the younger N 
group due to muscle maturity. However, the change in muscle strength was not 
significantly different between the H and N groups. 
It has been well documented that high intensity unaccustomed exercise or exercise 
involving significant eccentric actions will result in reduced muscle strength lasting up to 5-
          58
10 days post exercise (Armstrong, Warren & Warren,1991; Kuipers, 1994). The greatest 
disruption to the muscles ability to generate force is evident immediately following 
eccentric exercise, with muscle force slowly returning to normal over several days 
(Clarkson, Nosaka, & Braun, 1992). Talag (1972) assumed that strength decrements 
following eccentric muscle actions were due to pain which prevented maximal muscle 
activation. Furthermore, the loss of function following eccentric EIMD is associated with 
acute inflammation and DOMS (Smith, 1991). A loss of function implies an inability of the 
affected area to generate force. This loss of force is not completely understood but it is 
possible that a mechanical interference to the muscle was caused by swelling or a muscles 
reflex inhibition of the muscles experiencing pain which demonstrates a critical period for 
healing and the formation of new capillaries that are likely to be extremely fragile or the 
synthesis of new connective tissue (Peacock, 1984).  
   Newham et al., 1983 and Talag, 1973 investigated the time courses for 
development of soreness and for loss of strength and concluded there was little or no 
relationship between the two parameters. In support of these findings the present study 
revealed no significant change between strength measures or between groups over time. 
There was also no significant change in strength measures over time compared to baseline 
measures. However, soreness and tenderness were greater at 24hr post EIMD and remained 
greater than baseline measures at 120hr post EIMD. Clarkson & Tremblay, 1988; Newham 
et al., 1987 showed there was an immediate decrease in maximal force after eccentric 
exercise followed by a slow recovery whilst strength may remain depressed for seven days 
or longer (Neham et al., 1987). Interestingly, the present study revealed no significant 
change in strength immediately or over time compared to baseline measures, suggesting 
that the repeated bout of eccentric actions was not detrimental to the muscle to produce 
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force post-EIMD. As a result it is likely the EIMD protocol employed in the present study 
induced muscle damage to peripheral alterations which explains plasma CK increases. 
However, the damage to muscle tissue after EIMD may not have caused myofibrillar 
disruption, streaming or irregular z-lines, z-line material distributed throughout the 
sacromere, sarcolemma disruption, widening of A- and I-bands, displacement of organelles, 
increases in mitochondrial density. An interesting finding is that the N and H group 
strength measures were not significantly different suggesting that a hypoxic insult had no 
effect on EIMD recovery. Clearly some adaptation occurs in response to the initial 
microtrauma and subsequent healing which acts to protect the damaged muscle. It is clear 
that adaptations may last for a considerable period of time but it is not known how long 
after the initial eccentric exercise this adaptation occurs. Mechanical stress produced during 
EIMD actions may cause structural damage accompanied by a decrease in neuromuscular 
performance. This may suggest that if injury occurred only to the peripheral area of the 
muscle then motor units initially recruited initiate recruitment of additional units to produce 
the required forces. From the strength measures purported in the present study for the H and 
N groups it is obvious that the H treatment had no effect on the nervous or neurological 
system as the measures were not significantly different between the H and N groups or 
showed any significant decrement between baseline and post-EIMD testing times. 
  
5.2 Vertical Jump (Squat Jump)   
The present study hypothesized that recovery of SJ height after EIMD would be 
significantly different between the H and CON groups. The results of this study showed 
that SJ following EIMD was not significantly different between H and CON groups. The 
results also indicated that SJ height decline was greatest at 24hr for both the H and N 
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groups.  However, the H group’s SJ height did not return to baseline level by 120hr. 
Interestingly, SJ height for the N group returned to baseline levels by 48hr and 
progressively increased to 120hr post-EIMD. Previous studies (Eston et al., 1994; Eston et 
al., 1996; MacIntyre et al., 1996) investigated eccentric exercise, soreness and tenderness 
and presented evidence of muscle damage using eccentric torque and isometric strength. 
The present study was interested in the functional aspects associated with EIMD, including 
a modality specific to a performance. Therefore, SJ as a performance indicator was 
included to try and establish another muscle damage indicator.   
The results indicate that neither, the N or H, insult had an effect on muscle function when 
performing the SJ. Strength loss after EIMD seems to be independent of the muscle action 
being performed. However, the impairment of muscle function, SJ, was not attenuated 
when the stretch-shortening cycle was employed during the vertical jump exercise. It is 
possible that the stretch shortening cycle used in the SJ was unaffected as the eccentric 
exercised muscle is characterised by an inability to generate high force and power, however 
the elastic energy may have been able to maintain its ability to produce force and power. 
Such functional outcomes are consistent with the proposition that type II fibres are 
selectively recruited or damaged during eccentric exercise. The ability to maintain SJ 
height, following EIMD, suggests strength loss is mainly due to peripheral alterations and 
that alteration of the excitation-contraction coupling was not involved. Presently, there is no 
clear explanation for either the N condition SJ height increase in recovery or the magnitude 
of the H condition SJ height decline, but this finding suggests that 4hr hypoxia had no 
effect on SJ height, and likely muscle damage. 
 
 
          61
5.3 Plasma CK Activity  
In the present study, plasma CK activity in response to a short-term normobaric 
hypoxia insult following EIMD presented no significant difference between the H and N 
conditions (Figure 1). However, both groups showed a significant increase in CK activity 
after EIMD. Clarkson and Tremblay (1988) suggest that the muscle sacromeres are 
disrupted, misaligned, or a minor muscle tear occurs during eccentric actions causing a CK 
influx into the blood stream. This suggests that severe damage was produced in the 
exercised muscles during EIMD protocol of the present study as indicated by the increased 
CK measures at 24hr (Figure 1). It was hypothesized that CK activity for the H group 
would be significantly greater than the N group. The observed CK activity in the N group 
following EIMD showed that a mean peak response between 24-48hr post-EIMD, and 
supports Clarkson et al.’s (1987) findings. In comparison, the H group showed a mean peak 
at 96hr post-EIMD, similar to the finding of Schwane et. al., (1983a).  Although there was 
no significant difference between these groups as hypothesized, it is possible the post-
EIMD isokinetic and isometric testing may have interfered with EIMD recovery. Maximal 
efforts during the post-EIMD testing protocols may have caused further minor muscle 
damage in the H group as indicated by increased plasma CK levels at 72, 96 and 120hr 
post-EIMD, whilst isometric and isokinetic exercise performances may have been 
negatively affected. The delayed appearance of increased plasma CK activity that may have 
been caused by the post-isometric and isokinetic testing, and represent changes in 
sarcolemma integrity, focal necrosis and delayed muscle fibre regeneration.  
Clarkson et. al. (1987) has shown that repeating eccentric exercise with the same 
limb results in a reduced CK response following a second bout similar to that demonstrated 
by the N group. However, concentric and isometric muscle actions following an EIMD 
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bout may cause a greater CK response, as concentric contractions require a greater 
metabolic flux than eccentric contractions. Another likely explanation for the finding of no 
significant differences in CK levels between groups is that 4hr of hypoxia is not a long 
enough period to influence the recovery process.  
Following the process of inflammation, it is possible that normoxia affected 
recovery by limiting tissue edema and any possible potential for maintaining localized 
tissue pressure by minimizing the outflow of protein rich fluid from the plasma and its 
accumulation in the interstitial tissue (Armstrong, Warren, & Warren, 1991). Normoxia 
may also have inhibited the activation of the immune complexes, or a phagocytic challenge, 
neutrophils and macrophages as they release oxygen-derived free radicals and lysomal 
enzymes, which may have the potential to be detrimental during the inflammatory process 
(Armstrong et al., 1991). While O2 depravation to the stressed fragile muscle fibers could 
delay a noxious stimulus, which is responsible for the inflammatory response and the 
pathological reactions such as muscle tissue necrosis, repair and regeneration (Armstrong, 
Warren & Warren, 1991), it is possible that oxygen treatment after EIMD leads to the 
production of free radical scavengers that terminates lipid peroxidation and therefore 
regulates the recovering environment.  
 
5.4 Muscle Soreness and Tenderness   
Clinical symptoms associated with EIMD are soreness; perceived pain whilst 
performing movements such as walking, referred to as pain in the muscle during movement 
(Miles & Clarkson, 1994). The results show the N group’s perceived soreness returned to 
baseline levels between 48hr to 72hr, whilst the H group’s perceived soreness remained 
greater than that of baseline level. The high tensions placed on muscles and tendons 
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associated with eccentric contractions may cause a disruption to the connective tissue(s) 
inflicting painful sensations involving the activation of pain afferents, most likely type 
being III and IV nerve fibers (Mense & Stahnke, 1983). The sensation of pain, or soreness, 
in skeletal muscle is transmitted by myelinated group III (A-delta) and unmyelinated group 
IV (C) afferent fibers (Mense, 1977). Chemical substance(s) are required for generating 
painful sensations, the most likely being prostaglandins of the E series (Bomalaski, 
Williamson & Lurier, 1983), which do not directly cause pain, but sensitize pain receptors. 
These pain receptors are more likely to be activated by chemical, mechanical or thermal 
stimuli (Smith, 1991). However, it is still unclear which mechanisms cause the sensation of 
soreness. Consequently, on the basis of this study, and previous studies (Bomalaski, 
Williamson & Lurier, 1983 and Smith, 1991) one must be careful in concluding that the 
combination of modalities or one specific method is important in the development of 
soreness during recovery from EIMD.  Furthermore, chemical substances such as serotonin, 
histamine and potassium evoke an action potential on muscle group IV fibers providing a 
stimulus sufficient to increase perceived pain (Fock & Mense, 1976.). This concept 
receives some support from the present study which found strength levels after EIMD was 
greater in the N group than the H group and possibly reflects the perceived soreness levels 
and a reduced action potential.  
From the results of the present study it is not possible to suggest why the H 
condition may have resulted in a greater delay in soreness recovery to that of the N 
condition, other than to consider the importance of and the extent to which the controlled 
intervention of a hypoxic insult may have on the nervous system. It is suggested further 
research should emphasize investigating more variables in a prospective study design. It is 
acknowledged that the present study design involved two groups of not the same 
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individuals and that any future studies should use a repeated measures design whereby the 
same subjects are tested on two different occasions in a counterbalanced crossover fashion 
with an appropriate washout period. 
The eccentric EIMD protocol used in the present study produced tenderness in the 
N group (peaked at 24hr) and the H group (peaked at 48hr). However, Edwards Mills & 
Newham (1981) and Eston, Critchley & Baltzopoulos (1994), reported subject tenderness 
peaked 48hr after EIMD. It is not immediately apparent how the N or H condition affects 
the recovery from EIMD. The significant tenderness difference between the H and N 
condition observed at 48 and 72hr in the present study may reflect changes in intravascular 
volume. It is possible the H group tender muscles were spared compared to the N group, 
due to diminished muscle pump activation (McArdle, Katch & Katch, 1986, p329). It is 
therefore possible that any rise in resting blood flow (venous pooling) within the H group 
may be responsible for the observed muscle tenderness. Another possibility is that any 
increase in metabolite (calcium) accumulation within damaged muscle tissue, to abnormal 
levels, would result in a greater level of cell damage (McArdle, Katch & Katch, 1986, 
p329) and delay recovery from EIMD.  
The effect of hypoxia on EIMD recovery has not been previously investigated 
therefore, it is not known how the damaged muscle tissue reacts or why muscle-tenderness 
maybe affected by a mild hypoxic insult. One possible consideration is the biomechanical 
pathway responsible for cellular respiration. Respiratory physiology focuses on four 
integrated stages involved in external respiration, pulmonary ventilation, gas diffusion 
across the respiratory membrane, the storage and transport of oxygen and carbon dioxide 
and the exchange of dissolved gases. Abnormalities affecting anyone of these stages will 
affect the gas concentrations of the interstitial fluids and cellular activity (Martini, 1988, 
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p834). If the oxygen content were to decline the affected tissue would become oxygen-
starved and place severe limits on the metabolic activities of the affected area. If the oxygen 
supply were to be cut off completely, the condition of anoxia results and necrosis of the 
damaged muscle tissue occurs very quickly (Martin, 1988, p834).  
The ability to maintain cellular activity is an integral process during muscle tissue 
damage recovery. If the damaged muscle tissue is starved of oxygen, limiting the metabolic 
activity of that area, the muscle tenderness differences observed between groups in the 
present study maybe explained. The quantity of oxygen available to damaged muscle tissue 
seems to be a contentious issue and requires further research into a number of unanswered 
questions. 
 
5.5 Inflammatory Response 
Eccentric or unaccustomed exercise may result in temporary and repairable damage 
to skeletal muscle raging from focal disruption and ultrastructural damage to individual 
fibres of the muscle. When active muscle is stretched, damage can be caused to the 
myofibrils within the muscle, connective tissue linking adjacent myofribils, the basil lamina 
adjacent to plasma membranes, the plasma membrane of the myofibre, sarcomeres and 
sarcoplasmic reticulum, or a combination (Friden, Sjostrom & Ekblom, 1983; Stauber, 
1989). The immune system protects the body from invasion by creating local barriers and 
inflammation. The inflammatory response is to protect the tissues of the body to irritation 
or injury. It may be acute or chronic with signs of redness, heat, swelling, pain and a loss of 
function. The process begins with a brief increase in vascular permeability. Then a 
prolonged period consisting of a sustained increase in vascular permeability, excudation of 
fluids from the vessels, clustering of leukocytes along the vessel walls, phagocytosis of 
          66
microorganisms, deposition of fibrin in the vessel, disposal of the accumulated debris by 
macrophages and finally the migration of fibroblasts to the area and the development of 
new cells. The severity, timing and local character of any inflammatory response depends 
on the cause, the area affected and the condition of the host (Mosby’s 1990, p 620). It is 
generally considered that a group of cytokines, including interleukin-1, interferon, 
interleukin-2, interleukin-6 and tumour necrosis factor mediate the inflammatory process 
(Imura, Fukata & Mori, 1991). Although these cytokins were not measured in the present 
study there was no evidence of swelling, redness or associated loss of force which 
accompanies inflammatory response to injury. Based on the present study results, it is 
proposed that the eccentric exercise did not cause an inflammatory response. Although 
plasma CK measures increased they were not elevated as expected after EIMD. Damage to 
focal areas of muscle fibres with histological examination of the affected muscle shows 
myofibrillar disruption, streaming or irregular Z-lines, Z-line material distributed 
throughout the sacromere, sarcolemma disruption, widening of A and I-bands, 
displacement of organelles, increases in mitochondrial density and in the content of cyto-
skeletal and myofibrillar proteins (Kuipers et al., 1991). Although the present study did not 
measure these variables it is proposed that damage to the focal area of the affected muscle 
may have presented one of the histological examination measures as there was evidence of 
soreness and tenderness. The increased plasma CK in the circulation after exercise reflects 
muscle damage however the associated decrement in force was not seen suggesting the 
slightly damaged fibres were able to recruit more fibres to perform exercises after EIMD. 
The mechanical stress mechanism has been proposed to account for the damage caused by 
the shear forces produced during eccentric exercise. However, the metabolic stress 
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mechanism may have disturbed normal metabolic metabolism provoked by exhaustive 
endurance exercise such as eccentric actions.  
Following EIMD, a hypoxic insult was expected to reduce oxygen utilisation and 
overwhelm the capacity of the defence systems to scavenge reactive oxygen species and 
slow the oxidative damage to cellular components. Damage to the plasma membrane may 
lead to a loss in cell viability and possibly to cell necrosis over a longer period. Therefore, 
the immune response would involve a decrease in the rate of differentiation of monocytes 
and a decreased rate of transfer of mature monocytes from the bone marrow to the 
circulation. The possibility that hypoxic insult would be responsible for the delayed onset 
of neutrophils and macrophages invading skeletal muscle was the subject of debate. 
Neutrophils and macrophages which may extend to the inflammatory consequences of 
eccentric exercise and damaged muscle tissue by the release of reactive oxygen and 
nitrogen species, and cytokines is delayed. The pro-inflammatory cytokines interleukin 
(IL)-1β and tumor necrosis factor (TNF)-α would also be expressed within skeletal muscle 
over a longer period of time also delaying the inflammatory process and muscle damage 
recovery. IL-1β and TNF-α influence in initiating the breakdown of damaged muscle tissue 
would be less significant. Other cytokines such as IL-6 and transforming growth factor 
(TGF)-β1, and inflammatory antigens such as leukemia inhibitory factor (LIF) and hypoxia 
inducible factor (HIF)-1β also expressed in skeletal muscle in the days following eccentric 
exercise would appear less responsive.  
Inflammatory responses in muscle after eccentric exercise, the measurement of 
plasma CK allows for the comparison of responses to different types of post- EIMD 
measures. A large volume of data is available relating to changes in plasma CK and force 
production. Evidence suggests that changes were not significantly different. These non- 
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significant differences may reflect the influence of exercise intensities and muscle damage 
versus the effect of hypoxic insult. In addition to the muscle damage and functional activity 
alterations in damaged muscle tissue was minimal. There is no clear effect of a short term 
hypoxic insult after eccentric exercise on muscle damage recovery. This disparity might be 
due to differences in the type of eccentric exercise, exposure to previous eccentric exercise, 
as well as the methods used to measure soreness, tenderness and functional activity.  
 
Oxidative phosphorylation is the most important source of energy, oxygen capture, 
convective and diffusive oxygen transport, as well as the final intracellular oxygen 
utilisation within the mitochondria represents highly refined mechanisms, maintained by a 
number of physiological control systems. It is possible that any inflammatory process 
interfering with the delivery of oxygen to tissue will ultimately lead to an impairment of 
cellular energy production. Generally, cellular hypoxia may result from either reduced 
oxygen uptake (hypoxic hypoxia), reduced convective and diffusive oxygen transport 
(circulatory and anemic hypoxia), impaired oxygen consumption (histotoxic hypoxia), or a 
combination of these states. At present there is no definitive explanation which links the 
sequence of physiological responses (soreness, tenderness and decrement in force 
production) after EIMD. 
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CHAPTER SIX     
 
CONCLUSION 
 
The results of the present study showed that a 4hr hypoxic treatment after EIMD did 
not exacerbate muscle damage (MVC, plasma CK, soreness, tenderness, SJ) or retard the 
recovery process. Therefore, these results suggest that EIMD recovery is not affected by a 
hypoxic treatment. The non-significant difference evident between the H and N groups in 
the present study suggest athletes suffering from EIMD are reasonably assured that a short, 
4hr, air-flight (H insult) will not increase EIMD recovery time compared to N insult.  
A weakness of this study was in the subject numbers used and the fact that two 
groups of different subjects were used. Also, the development and recovery of any injury is 
influenced by many intrinsic and extrinsic factors. The fact that only a hypoxic condition 
influence on EIMD recovery was examined could also be considered a limitation of this 
study.    
It is recommended that further research into the effects of a hypoxia insult following 
exercise on muscle damage recovery include protocols that include two subject groups 
which participate in both a normoxic and hypoxic insult. Other possible reasons for delays 
in EIMD recovery following air travel include cramped and static positions, and perhaps 
further studies should also attempt to examine this. 
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CHAPTER SEVEN     
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Appendix A 
 
INFORMED CONSENT FORM 
 
Project Title:  Effects of Hypoxia on Exercise Induced Muscle Damage. 
 
Purpose of the Investigation: 
The purpose of this investigation is to determine if exposure to four hours of hypoxia, 
similar to that experienced during air-travel, delays the recovery from eccentric exercise-
induced muscle damage. The recovery from muscle damage will be assessed by variables 
routinely used to diagnose muscle damage. It is hypothesized that exposure to hypoxia will 
prolong the recovery from muscle damage and cause larger and more sustained changes in 
all dependant variables over the ten-day study.   
 
Procedures of the study: 
This investigation will be conducted over an eight-day period at Edith Cowan University, 
Joondalup campus. Subjects participating in the investigation will be required to answer a 
health screening and risk stratification questionnaire (see Appendix B) as outlined by the 
American College of Sports Medicine.  
 
The purposes of the pre-participation screening include:   
• identify and exclude individuals with medical contraindications to exercise.  
• identify individuals with disease symptoms and risk factors for disease development 
who should receive medical evaluation before starting an exercise program.  
• identify persons with clinically significant disease considerations who should 
participate in a medically supervised exercise program.  
• identify individuals with other special needs. 
 
Once you, the potential subject, have been assessed and passed all pre-participation 
screening criteria you will then be invited to participate in the present investigation. Subject 
will then be randomly assigned to either test or control group. 
 
Testing; 
Testing will consist of seven visits to the laboratory. We may stop the test at any time 
because of signs of fatigue or observed changes indicating risks or extreme discomfort to 
the subject. It is important for you to realize that you may stop when you wish because of 
feelings of fatigue or any other discomfort. 
 
Test 1 & 2;  
Subject height (cm); body mass (Kg), test limb circumference (cm); Resting Heart Rate, 
Muscle soreness & tenderness; Creatine kinase; Isometric strength; Isokinetic torque & 
Vertical jump height (cm) will be measured and recorded as baseline measures.  
You will perform an exercise warm-up; 5-minute cycle (ergometer) and 3-minute stretch on 
muscle groups of the leg; immediately followed by a isometric and isokinetic exercise test 
on subject dominant leg using a cybex 6000 dynamometer.  
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Test 3;  
Subjects will be requested to perform an exercise warm-up (Test 1 warm-up), followed by 
an intermittent eccentric action of the knee extensor muscle group. All subjects will be 
requested to perform 10 reps x 6 sets of eccentric contractions, of the dominant leg at the 
angle from 00 to 900. Subjects will eccentric actions (extension/flexion) at a rate of 90 per 
second, with a 20-second inter-trail rest, the six sets will be separated by 2 minutes of rest.  
Immediately following the eccentric exercise protocol, a cool down exercise protocol (Test 
1 warm-up, at a lower intensity) will be performed.  
 
Immediately following the cool down, subject will be exposed to either normobaric 
hypoxia condition (test group) or normal ambient condition (control group) protocol. 
Subject in the test group will be requested to sit in an isolated room (heat chamber, SOBSS 
laboratory) and breath a medical grade gas; oxygen (15.37%) and nitrogen (84.63%) mild 
hypoxia, this gas will be pumped from a tissot tank into the isolated room. Subject in the 
control group will be requested to sit in a, different but similar, isolated room and breath 
normal ambient air. 
 
Tests 4-8;  
Subject will be requested to visit the laboratory on 5 different (24, 48, 72, 96 &120 Hr post 
eccentric exercise protocol) occasions. Subjects variables to be measured; limb 
circumference (cm); Muscle soreness & tenderness; Creatine kinase levels; Isometric 
strength; Isokinetic torque & Vertical jump height (cm) to evaluate recovery and compare 
post-exercise measures to baseline measures.  
 
Subject risks and discomforts;  
Subject is likely to experience leg soreness, tenderness and stiffness, in the thigh and 
gluteal region, in the days following the eccentric exercise protocol. However, this should 
dissipate within 5-7 days post exercise. Every effort will be made to minimize the risks of 
abnormal blood pressure, fainting, heart attack, stroke, or death by evaluation of 
preliminary information relating to your health and fitness and by observation during 
testing. Emergency equipment and trained personal are available to deal with unusual 
situations that may arise. 
 
• The investigator(s) ask that you do not make any changes to your daily activities, 
eating plan or take any medication, anti-inflammation drug(s) or similar as this 
may influence results. 
 
Responsibilities of the subject;  
The information you, the subject, posses about your health status or previous experiences of 
unusual feelings with physical effort may affect the safety and value of your exercise test. 
Your prompt reporting of feelings with effort during exercise test itself is also of great 
importance. You are responsible for fully disclosing such information when requested by 
the researcher(s). 
 
Benefits to the subject;  
The results and experiences obtained from the exercise test and participation in the present 
investigation may assist you in understanding recovery methods and recovery times 
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following exercise-induced muscle damage and the effects of hypoxia (air-travel) on 
muscle damage recovery. Information gained may provide the subject with periodization 
strategies for training following competition(s).   
 
Inquiries;  
Questions concerning this investigation may be directed to: 
 
Trevor Farr BSc. (Hons);                 MSc. candidate;        email:
   
 
Dr Fiona Naumann                Supervisor;                email: f.naumann@ecu.edu.au
 9400 5012 
 
Freedom of consent; 
Your permission to perform this exercise test is voluntary. You are free to stop the test at 
any point, if you so desire, and you may withdraw at any time for any reason. 
All information will be secured under lock and key by the researchers. Data entry and 
analysis of that data will not include any name or information that may identify or link an 
individual as a subject. 
 
I agree that the research data gathered for this study may be published provided I am not 
identifiable. 
 
I (the participant) have read this form, and I understand the test procedures that I will 
perform and the associated risks and discomforts. Knowing these risks and discomforts and 
having had an opportunity to ask questions that have been answered to my satisfaction. I 
agree to participate in this research project. 
 
 
Signature of Participant: _______________________ Date:_____:_____:_____ 
 
 
Signature of Investigator: Trevor Farr BSc (Hons);        
 
 
                                       _______________________  Date: ____:_____:_____ 
 
 
 
 
 
 
 
 
          81
Appendix B 
 
MEDICAL QUESTIONNAIRE 
 
The following questionnaire is designed to establish a background of your medical history, 
and identify any injury or illness that may influence your testing or performance. Please 
answer all questions as accurately as possible, if you are unsure about anything please ask 
investigator(s) (see Appendix, p. 3 Inquiries). All information provided is strictly 
confidential. 
 
Personal Details 
Name: ____________________________________ 
 
DOB: _____:_____:_____     
 
Height:                   cm   Body Mass:            Kg 
 
Medical History 
 
Have you ever had, or do you currently have any of the following? 
 
If you answer “YES” please give details 
 
High or abnormal blood pressure            Y N
 __________________________________ 
High cholesterol              Y N
 __________________________________ 
Rheumatic fever              Y N
 __________________________________ 
Heart abnormalities              Y N
 __________________________________ 
Asthma               Y N __________________________________ 
Diabetes               Y N
 __________________________________ 
Epilepsy               Y N
 __________________________________ 
Back pain               Y N
 __________________________________ 
Neck pain               Y N
 __________________________________ 
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Severe allergies              Y N __________________________________ 
Any infectious diseases             Y N __________________________________ 
         
If you answered YES please give details 
    
Are you currently on any medication(s)?                 Y        N 
 
 __________________________________ 
 
Have you had the flu in the last two weeks?     Y        N 
 
 __________________________________ 
 
 
Have you recently had any injuries or accidents?   Y N 
 
 __________________________________ 
    
 
Do you have a recurring muscle or joint injury?      Y N 
 
 __________________________________ 
 
Suffer any condition(s) not previously mentioned    
which may affect your exercise performance?     Y   N    
 
 __________________________________ 
 
Family History 
 
Are there any of the following known exist in your family? 
 
   If you answer “YES” please give details 
 
Cardiac disease                    Y N 
             __________________________________ 
Pulmonary disease       Y N
 __________________________________ 
Stroke                               Y N
 __________________________________ 
 
Lifestyle Habits 
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Do you exercise regularly?   Y N  
If YES how many hours per week?    ____________  
 
Do you smoke tobacco or any    
other nicotine products?                Y N 
If YES, please indicate how many per day               _____________ 
      
Do you consume alcohol?   Y N   
If YES how many standard drinks  
per week?       ____________ 
 
 
Do you consume tea or coffee?               Y N 
If YES how many cups per day?    ____________ 
 
 
Declaration 
 
I acknowledge that the information provided on this form, is to the best of my knowledge, a true 
and accurate indication of my current state of health. 
 
 
Name:    ________________________________        Date: _____:_____:_____ 
 
 
 
Signature:    ____________________________        
 
 
 
Witness: Trevor Farr                                                      Date: _____:_____:_____    
 
 
 
Signature:    ____________________________        
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Appendix C 
 
Rating Muscle Soreness 
 
 
 
Scale: 1 = normal, 10 = very, very sore 
 
_________________________________________________ 
 
1    -   Normal 
 
2    -    
 
3 - Somewhat Sore 
 
4 -  
 
5 - Moderately Sore 
 
6 -  
 
7 -  
 
8 - Very Sore 
 
9 -  
 
10 - Very, Very Sore 
 
_________________________________________________ 
 
 
Adapted from Clarkson, P.M., & Tremblay, I. (1988). Exercise-induced muscle damage, 
repair, and adaptation in humans. Journal of Applied Physiology, 65 (1), 1-6. 
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       Appendix D 
Reliability, Raw and Normalised Data 
  
Isokinetic Peak Torque (Nm) for Hypoxic Group and Normoxic Group at 60 deg/s  
                 
  Hypoxic Group   Normoxic Group  
Subject   Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  182 197 15  192 204 12 
2  207 217 10  172 180 8 
3  178 174 -4  230 242 12 
4  140 148 8  150 152 2 
5  123 127 4  192 205 13 
6  120 122 2  130 146 16 
7  198 204 6  140 136 -4 
8  142 150 8  240 250 10 
         
Mean  161.25 167.38 -6.13  180.75 189.38 -8.63 
SD  34.10 36.04 5.67  40.44 43.29 6.57 
SEM  12.06 12.74 2.00  14.30 15.31 2.32 
ME     4.01    4.64 
V    2.44    2.51 
Correlation         
coefficient (r)     -3.06      -3.71 
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Isokinetic Peak Torque (Nm) for Hypoxic Group and Normoxic Group at 120 deg/s  
         
              
  Hypoxic Group   Normoxic Group   
Subject   Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  150 160 10  124 130 6 
2  190 170 -20  177 183 6 
3  182 178 -4  210 226 16 
4  120 126 6  139 135 -4 
5  114 120 6  150 154 4 
6  97 101 4  126 133 7 
7  200 210 10  142 130 -12 
8  164 170 6  212 220 8 
         
Mean  152.13 154.38 -2.25  160.00 163.88 -3.88 
SD  38.34 35.87 10.00  35.48 40.63 8.43 
SEM  13.55 12.68 3.53  12.54 14.36 2.98 
ME     7.07    5.96 
V    4.61    3.68 
Correlation         
coefficient (r)     -0.64      -1.30 
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Isokinetic Peak Torque (Nm) for Hypoxic Group and Normoxic Group at 240 deg/s  
              
 Hypoxic Group   Normoxic Group   
Subject   
 
Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  109 103 -6  72 80 8 
2  128 130 2  130 142 12 
3  119 123 4  193 189 -4 
4  90 92 2  64 68 4 
5  83 91 8  130 120 -10 
6  80 70 -10  100 108 8 
7  160 168 8  70 80 10 
8  110 118 8  172 180 8 
         
Mean  109.88 111.88 -2.00  116.38 120.88 -4.50 
SD  26.55 30.01 6.76  48.50 46.12 7.62 
SEM  9.39 10.61 2.39  17.15 16.30 2.69 
ME      4.78    5.39 
V    4.31    4.54 
Correlation         
coefficient (r)     -0.84       -1.67 
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Isometric Peak Torque (Nm) for Hypoxic Group and Normoxic Group at 35 deg  
              
  Hypoxic Group   Normoxic Group   
Subject   Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  143 139 -4  215 225 10 
2  142 150 8  156 170 14 
3  112 124 12  207 211 4 
4  107 115 8  136 140 4 
5  141 149 8  156 148 -8 
6  134 142 8  154 160 6 
7  230 242 12  132 150 18 
8  160 166 6  200 218 18 
         
Mean  146.13 153.38 -7.25  169.50 177.75 -8.25 
SD  38.03 39.13 5.01  32.82 34.67 8.71 
SEM  13.44 13.83 1.77  11.60 12.26 3.08 
ME      3.54    6.16 
V    2.36    3.55 
Correlation         
coefficient (r)     -4.10       -2.68 
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Isometric Peak Torque (Nm) for Hypoxic Group and Normoxic Group at 55 deg  
              
  Hypoxic Group   Normoxic Group   
Subject   Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  224 212 -12  319 307 -12 
2  207 217 10  223 236 13 
3  190 204 14  300 330 30 
4  130 150 20  180 196 16 
5  168 180 12  219 245 26 
6  184 190 6  182 198 16 
7  295 315 20  220 200 -20 
8  210 216 6  258 250 -8 
         
Mean  201.00 210.50 -9.50  237.63 245.25 -7.63 
SD  47.84 47.88 10.24  51.01 50.44 18.52 
SEM  16.91 16.93 3.62  18.03 17.83 6.55 
ME      7.24    13.09 
V    3.52    5.42 
Correlation         
coefficient (r)     -2.62       -1.16 
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Isometric Peak Torque (Nm) for Hypoxic Group and Normoxic Group at 75 deg  
              
  Hypoxic Group   Normoxic Group   
Subject   Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  220 238 18  340 360 20 
2  191 203 12  200 218 18 
3  220 230 10  364 360 -4 
4  164 180 16  215 225 10 
5  160 168 8  296 306 10 
6  200 194 -6  175 193 18 
7  340 324 -16  253 225 -28 
8  228 220 -8  220 230 10 
         
Mean  215.38 219.63 -4.25  257.88 264.63 -6.75 
SD  56.40 48.56 12.53  68.63 67.13 15.96 
SEM  19.94 17.17 4.43  24.27 23.74 5.64 
ME      8.86    11.29 
V    4.07    4.32 
Correlation         
coefficient (r)     -0.96       -1.20 
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Vertical Jump (cm) measures for Hypoxic Group and Normoxic Group    
              
  Hypoxic Group   Normoxic Group   
Subject   Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  29.4 35 5.60  30.8 29.4 -1.40 
2  15.4 18.2 2.80  35 36.4 1.40 
3  36.4 42 5.60   35 37.8 2.80 
4  33.6 33.6 0.00  36.4 37.8 1.40 
5  23.8 28 4.20  28 29.4 1.40 
6  29.8 25.2 -4.60  25.2 28 2.80 
7  30.8 30.8 0.00  37.8 40.6 2.80 
8  39.2 40.6 1.40  47.6 47.6 0.00 
         
Mean  29.80 31.68 -1.88  34.48 35.88 -1.40 
SD  7.47 7.92 3.45  6.86 6.69 1.50 
SEM  2.64 2.80 1.22   2.42 2.37 0.53 
ME     2.44     1.06 
V    7.93    3.01 
Correlation         
coefficient (r)     -1.54       -2.65
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Plasma CK (mmol) measures for Hypoxic Group and Normoxic Group    
         
  Hypoxic Group    Normoxic Group   
Subject   Test 1 Test 2 Difference  Test 1 Test 2 Difference 
1  247 230 -17  90 93 3 
2  98.60 94 -5  163 152 -11 
3  133 137 4  121 126 5 
4  165 153 -12  153 142 -11 
5  189 190 1  190 170 -20 
6  95.30 92 -3  107 101 -6 
7  138 120 -18  128 130 2 
8  60 70 10  202 200 -2 
           
Mean  140.74 135.75 4.99  144.25 139.25 5.00 
SD  59.32 53.92 10.05  39.63 35.19 8.62 
SEM  20.97 19.06 3.55   14.01 12.44 3.05 
ME     7.11     6.09 
V    5.14    4.30 
Correlation         
coefficient (r)     1.40       1.64
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Creatine kinase (IU/L) activity 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 239 254 314 348 308 453 N1 92 193 140 168 238 140
H2 97 180 176 114 176 101 N2 158 375 283 306 515 387
H3 135 288 174 190 167 337 N3 124 209 177 218 98 97
H4 159 658 631 682 661 328 N4 148 188 557 225 286 108
H5 190 237 148 156 219 241 N5 180 448 303 256 170 165
H6 94 133 161 408 466 414 N6 104 226 180 151 120 125
H7 129 230 273 262 321 235 N7 129 241 232 186 184 205
H8 65 101 61 67.60 62.90 90.2 N8 201 345 371 598 330 398
Mean 138.25 260.13 242.25 278.45 297.61 274.90 141.75 278.13 280.38 263.50 242.68 203.09
SD 56.46 172.57 175.09 199.66 190.56 133.55  37.23 97.80 135.26 143.97 135.37 121.72
SEM 19.96 61.01 61.90 70.59 67.37 47.22 13.16 34.58 47.82 50.90 47.86 43.03
t test time 0.07 0.44 0.30 0.27 0.70 0.00 0.97 0.77 0.69 0.23
t test group 0.83 0.50 0.89 0.56 0.44
Percent Change for Creatine kinase (IU/L) activity   
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 6.50 31.66 45.91 29.14 89.94 N1 0.00 110.93 53.01 83.61 160.11 53.01
H2 0.00 86.53 82.38 18.13 82.38 4.66 N2 0.00 138.10 79.68 94.29 226.98 145.71
H3 0.00 113.33 28.89 40.74 23.70 149.63 N3 0.00 69.23 43.32 76.52 -20.32 -21.70
H4 0.00 313.84 296.86 328.93 315.72 106.29 N4 0.00 27.46 277.63 52.54 93.90 -26.78
H5 0.00 25.07 -21.90 -17.68 15.57 27.18 N5 0.00 148.89 68.33 42.22 -5.56 -8.33
H6 0.00 42.25 72.19 336.36 398.40 342.78 N6 0.00 117.31 73.08 45.19 15.38 20.19
H7 0.00 78.29 111.63 103.10 148.84 82.17 N7 0.00 86.82 79.84 44.19 42.64 58.91
H8 0.00 55.38 -6.15 4.00 -3.23 38.77 N8 0.00 71.64 84.58 197.51 64.18 98.01
Mean 0.00 97.92 81.68 125.40 144.15 120.08 0.00 101.98 99.17 65.73 78.42 27.02
SD 0.00 96.71 100.43 143.45 151.83 106.77 0.00 40.25 75.17 51.70 85.30 61.02
SEM 0.00 34.19 35.51 50.72 53.68 37.75 0.00 14.23 26.58 18.28 30.16 21.57
t test time 0.03 0.36 0.37 0.18 0.58 0.00 0.97 0.67 0.82 0.18
t test group 0.90 0.25 0.66 0.42 0.24
  
Muscle Soreness 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120  
H1 1 5 3 2 1 1 N1 1 1 1 1 1 1
H2 1 2 1 1 1 1 N2 1 2 3 1 1 1
H3 1 2 2 2 1 1 N3 1 2 1 1 1 1
H4 1 3 3 1 1 1 N4 1 3 2 2 1 1
H5 1 6 4 3 2 2 N5 1 3 2 1 1 1
H6 1 4 5 2 1.5 1 N6 1 2.5 1 1 1 1
H7 1 2 4 2 1 1 N7 1 3 1 1 1 1
H8 1 1 3 1 1 1 N8 1 2 2 1 1 2
Mean 1.00 3.67 3.00 1.83 1.25 1.17 1.00 2.25 1.67 1.17 1.00 1.00
SD 0.00 1.63 1.41 0.75 0.42 0.41 0.00 0.76 0.82 0.41 0.00 0.00
SEM 0.00 0.58 0.50 0.27 0.15 0.14 0.00 0.27 0.29 0.14 0.00 0.00  
t test time 0.01 1.00 0.01 0.01 0.35 0.00 0.08 0.10 0.35 0.35
t test group 0.25 0.05 0.09 0.20 1.00
Percent Change for Muscle Soreness 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 400.00 200.00 100.00 0.00 0.00 N1 0.00 0.00 0.00 0.00 0.00 0.00
H2 0.00 100.00 0.00 0.00 0.00 0.00 N2 0.00 100.00 200.00 0.00 0.00 0.00
H3 0.00 100.00 100.00 100.00 0.00 0.00 N3 0.00 100.00 0.00 0.00 0.00 0.00
H4 0.00 200.00 200.00 0.00 0.00 0.00 N4 0.00 200.00 100.00 100.00 0.00 0.00
H5 0.00 500.00 300.00 200.00 100.00 100.00 N5 0.00 200.00 100.00 0.00 0.00 0.00
H6 0.00 300.00 400.00 100.00 50.00 0.00 N6 0.00 150.00 0.00 0.00 0.00 0.00
H7 0.00 100.00 300.00 100.00 0.00 0.00 N7 0.00 200.00 0.00 0.00 0.00 0.00
H8 0.00 0.00 200.00 0.00 0.00 0.00 N8 0.00 100.00 100.00 0.00 0.00 100.00
Mean 0.00 266.67 200.00 83.33 25.00 16.67 0.00 125.00 66.67 16.67 0.00 0.00
SD 0.00 163.30 141.42 75.28 41.83 40.82 0.00 75.83 81.65 40.82 0.00 0.00
SEM 0.00 57.74 50.00 26.61 14.79 14.43 0.00 26.81 28.87 14.43 0.00 0.00
t test time 0.01 1.00 0.01 0.01 0.35 0.00 0.08 0.10 0.35 0.35
t test group 0.25 0.05 0.09 0.20 1.00
Muscle Tenderness (mean of 6 sites) 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 100 50.80 22.10 48 70.80 87 N1 100 62 62 95 95.80 97.50
H2 100 82.60 98 98 100 100 N2 100 70.80 79 80.80 94 100
H3 100 98 94 100 100 96.60 N3 100 95 95.40 96.60 100 100
H4 100 95 95 96.60 100 100 N4 100 82.90 100 100 100 100
H5 100 93 87.50 88.75 98 100 N5 100 97.50 98.60 100 100 100  
H6 100 74 77.50 91.60 97.50 100 N6 100 64 75.80 88.80 96.30 98.60
H7 100 114.16 100 100 100 100 N7 100 100 100 100 100 100
H8 100 97.50 98.30 100 100 100 N8 100 100 99.16 100 100 100
Mean 100.00 82.23 79.02 87.16 94.38 97.27 100.00 78.70 85.13 93.53 97.68 99.35
SD 0.00 17.80 28.82 19.63 11.61 5.21 0.00 15.45 15.28 7.48 2.65 1.07
SEM 0.00 6.29 10.19 6.94 4.10 1.84 0.00 5.46 5.40 2.64 0.94 0.38
t test time 0.12 0.40 0.09 0.09 0.34 0.03 0.09 0.16 0.11 0.14
t test group 0.25 0.45 0.50 0.48 0.29
Percent Change for Muscle Tenderness (mean of 6 sites) 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 50.80 22.10 94.49 70.80 87.00 N1 0.00 62.00 62.00 95.00 154.52 97.50
H2 0.00 82.60 98.00 118.64 100.00 100.00 N2 0.00 70.80 79.00 80.80 118.99 100.00
H3 0.00 98.00 94.00 102.04 100.00 96.60 N3 0.00 95.00 95.40 96.60 104.82 100.00
H4 0.00 95.00 95.00 101.68 100.00 100.00 N4 0.00 82.90 100.00 100.00 100.00 100.00
H5 0.00 93.00 87.50 95.43 98.00 100.00 N5 0.00 97.50 98.60 100.00 101.42 100.00
H6 0.00 74.00 77.50 123.78 97.50 100.00 N6 0.00 64.00 75.80 88.80 127.04 98.60
H7 0.00 114.16 100.00 87.60 100.00 100.00 N7 0.00 100.00 100.00 100.00 100.00 100.00
H8 0.00 97.50 98.30 102.56 100.00 100.00 N8 0.00 100.00 99.16 100.00 100.85 100.00
Mean 0.00 82.23 79.02 106.01 94.38 97.27 0.00 78.70 85.13 93.53 117.80 99.35   
SD 0.00 17.80 28.82 12.29 11.61 5.21 0.00 15.45 15.28 7.48 20.92 1.07
SEM 0.00 6.29 10.19 4.34 4.10 1.84 0.00 5.46 5.40 2.64 7.40 0.38
t test time 0.00 0.40 0.09 0.17 0.34 0.00 0.09 0.16 0.06 0.09
t test group 0.25 0.45 0.25 0.13 0.29
Extensor Isokinetic Peak Torque (Nm) for 120 deg/sec  
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 155 155 193 151 134 156 N1 127 167 165 176 167 186
H2 180 174 173 160 183 186 N2 180 160 144 180 178 170
H3 180 186 183 191 206 197 N3 218 205 235 245 232 225
H4 123 129 130 127 138 125 N4 137 164 182 142 170 171
H5 117 79 104 94 104 115 N5 152 167 175 184 184 179
H6 99 83 92 85 75 77 N6 129 119 138 123 138 152
H7 205 182 201 197 187 199 N7 136 111 99 125 126 137
H8 167 164 157 156 174 159 N8 216 241 254 244 220 209
Mean 153.25 144.00 154.13 145.13 150.13 151.75 161.88 166.75 174.00 177.38 176.88 178.63
SD 36.79 42.76 41.16 40.93 45.22 43.39 37.97 42.12 50.83 47.83 36.24 28.54
SEM 13.01 15.12 14.55 14.47 15.99 15.34 13.42 14.89 17.97 16.91 12.81 10.09
t test time 0.13 0.11 0.13 0.38 0.74 0.59 0.24 0.71 0.93 0.68
t test group 0.24 0.43 0.12 0.13 0.14  
 
Normalised Extensor Isokinetic Peak Torque (Nm) for 120 deg/sec 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 0.00 24.52 -2.58 -13.55 0.65 N1 0.00 31.50 29.92 38.58 31.50 46.46
H2 0.00 -3.33 -3.89 -11.11 1.67 3.33 N2 0.00 -11.11 -20.00 0.00 -1.11 -5.56
H3 0.00 3.33 1.67 6.11 14.44 9.44 N3 0.00 -5.96 7.80 12.39 6.42 3.21
H4 0.00 4.88 5.69 3.25 12.20 1.63 N4 0.00 19.71 32.85 3.65 24.09 24.82  
H5 0.00 -32.48 -11.11 -19.66 -11.11 -1.71 N5 0.00 9.87 15.13 21.05 21.05 17.76
H6 0.00 -16.16 -7.07 -14.14 -24.24 -22.22 N6 0.00 -7.75 6.98 -4.65 6.98 17.83
H7 0.00 -11.22 -1.95 -3.90 -8.78 -2.93 N7 0.00 -18.38 -27.21 -8.09 -7.35 0.74
H8 0.00 -1.80 -5.99 -6.59 4.19 -4.79 N8 0.00 11.57 17.59 12.96 1.85 -3.24
Mean 0.00 -7.10 0.23 -6.08 -3.15 -2.07 0.00 3.68 7.88 9.49 10.43 12.75
SD 0.00 12.47 11.11 8.68 13.47 9.24 0.00 17.16 21.60 15.28 13.60 17.56  
SEM 0.00 4.41 3.93 3.07 4.76 3.27 0.00 6.07 7.64 5.40 4.81 6.21
t test time 0.15 0.10 0.10 0.43 0.74 0.56 0.26 0.79 0.81 0.43
t test group 0.15 0.30 0.04 0.10 0.08
Extensor Isokinetic Peak Torque (Nm) for 240 deg/sec  
 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 106 99 110 99 99 100 N1 76 127 125 127 114 133
H2 129 145 134 118 132 145 N2 136 136 161 142 156 149
H3 121 137 132 140 144 141 N3 191 180 184 191 183 176
H4 91 126 98 113 130 117 N4 66 103 111 81 113 130
H5 87 64 79 68 77 81 N5 125 103 121 104 106 132
H6 65 68 72 60 61 57 N6 104 85 96 107 99 103
H7 164 133 167 159 126 167 N7 75 61 61 57 75 69
H8 114 118 119 145 130 127 N8 176 160 197 182 182 179
Mean 109.63 111.25 113.88 112.75 112.38 116.88 118.63 119.38 132.00 123.88 128.50 133.88
SD 30.10 31.15 31.21 35.70 29.91 36.14 47.17 39.25 45.85 46.62 40.14 36.29
SEM 10.64 11.01 11.03 12.62 10.57 12.78 16.68 13.88 16.21 16.48 14.19 12.83
t test time 0.84 0.70 0.84 0.95 0.47 0.94 0.03 0.15 0.43 0.29
t test group 0.59 0.38 0.57 0.22 0.36
 
Normalised Extensor Isokinetic Peak Torque (Nm) for 240 deg/sec 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 -6.60 3.77 -6.60 -6.60 -5.66 N1 0.00 67.11 64.47 67.11 50.00 75.00
H2 0.00 12.40 3.88 -8.53 2.33 12.40 N2 0.00 0.00 18.38 4.41 14.71 9.56
H3 0.00 13.22 9.09 15.70 19.01 16.53 N3 0.00 -5.76 -3.66 0.00 -4.19 -7.85
H4 0.00 38.46 7.69 24.18 42.86 28.57 N4 0.00 56.06 68.18 22.73 71.21 96.97
H5 0.00 -26.44 -9.20 -21.84 -11.49 -6.90 N5 0.00 -17.60 -3.20 -16.80 -15.20 5.60
H6 0.00 4.62 10.77 -7.69 -6.15 -12.31 N6 0.00 -18.27 -7.69 2.88 -4.81 -0.96
H7 0.00 -18.90 1.83 -3.05 -23.17 1.83 N7 0.00 -18.67 -18.67 -24.00 0.00 -8.00
H8 0.00 3.51 4.39 27.19 14.04 11.40 N8 0.00 -9.09 11.93 3.41 3.41 1.70
Mean 0.00 2.53 4.03 2.42 3.85 5.73 0.00 6.72 16.22 7.47 14.39 21.50
SD 0.00 20.32 6.15 17.67 20.81 13.86 0.00 34.62 32.98 27.96 30.27 40.68
SEM 0.00 7.18 2.17 6.25 7.36 4.90 0.00 12.24 11.66 9.88 10.70 14.38
t test time 0.73 0.80 0.77 0.76 0.67 0.60 0.02 0.19 0.38 0.20
t test group 0.72 0.32 0.66 0.28 0.28  
Isometric Peak Strength (Nm/kg) at 75 deg of Knee Flexion
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 229.00 201.00 231.00 217.00 254.00 258.00 N1 350.00 301.00 370.00 363.00 363.00 366.00
H2 197.00 277.00 292.00 275.00 312.00 316.00 N2 209.00 197.00 278.00 259.00 275.00 335.00
H3 225.00 245.00 247.00 267.00 264.00 267.00 N3 362.00 316.00 355.00 342.00 320.00 331.00
H4 172.00 197.00 207.00 213.00 221.00 206.00 N4 220.00 243.00 275.00 243.00 283.00 287.00
H5 164.00 159.00 122.00 127.00 161.00 216.00 N5 301.00 344.00 377.00 391.00 395.00 420.00
H6 197.00 178.00 225.00 233.00 240.00 252.00 N6 184.00 179.00 206.00 213.00 216.00 245.00
H7 332.00 336.00 365.00 411.00 365.00 359.00 N7 239.00 222.00 182.00 235.00 214.00 225.00
H8 224.00 251.00 232.00 264.00 264.00 277.00 N8 225.00 275.00 271.00 321.00 335.00 347.00
Mean 217.50 230.50 240.13 250.88 260.13 268.88 261.25 259.63 289.25 295.88 300.13 319.50
SD 52.25 58.29 69.45 80.09 60.38 50.09 67.42 58.99 73.33 66.59 65.45 64.29
SEM 18.47 20.61 24.55 28.32 21.35 17.71 23.84 20.86 25.93 23.54 23.14 22.73
t test time 0.31 0.35 0.20 0.38 0.27 0.91 0.07 0.57 0.57 0.02
t test group 0.42 0.32 0.36 0.35 0.19
Percent Change for Isometric Peak Strength at 75 deg of Knee Flexion
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 -12.23 0.87 -5.24 10.92 12.66 N1 0.00 -14.00 5.71 3.71 3.71 4.57
H2 0.00 40.61 48.22 39.59 58.38 60.41 N2 0.00 -5.74 33.01 23.92 31.58 60.29
H3 0.00 8.89 9.78 18.67 17.33 18.67 N3 0.00 -12.71 -1.93 -5.52 -11.60 -8.56
H4 0.00 14.53 20.35 23.84 28.49 19.77 N4 0.00 10.45 25.00 10.45 28.64 30.45
H5 0.00 -3.05 -25.61 -22.56 -1.83 31.71 N5 0.00 14.29 25.25 29.90 31.23 39.53
H6 0.00 -9.64 14.21 18.27 21.83 27.92 N6 0.00 -2.72 11.96 15.76 17.39 33.15
H7 0.00 1.20 9.94 23.80 9.94 8.13 N7 0.00 -7.11 -23.85 -1.67 -10.46 -5.86
H8 0.00 12.05 3.57 17.86 17.86 23.66 N8 0.00 22.22 20.44 42.67 48.89 54.22
Mean 0.00 6.55 10.17 14.28 20.36 25.37 0.00 0.59 11.95 14.90 17.42 25.98
SD 0.00 16.88 20.63 19.31 17.80 16.09 0.00 13.38 18.42 16.54 21.76 26.44
SEM 0.00 5.97 7.29 6.83 6.29 5.69 0.00 4.73 6.51 5.85 7.69 9.35
t test time 0.31 0.49 0.21 0.19 0.29 0.90 0.09 0.55 0.43 0.04
t test group 0.43 0.85 0.95 0.74 0.92
 
Isometric Peak Strength (Nm/kg) at 55 deg of Knee Flexion
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 218.00 108.00 198.00 206.00 216.00 241.00 N1 313.00 260.00 306.00 308.00 305.00 312.00
H2 212.00 235.00 260.00 270.00 289.00 286.00 N2 229.00 241.00 271.00 296.00 315.00 296.00
H3 194.00 190.00 210.00 213.00 217.00 217.00 N3 315.00 312.00 332.00 361.00 330.00 323.00
H4 140.00 156.00 167.00 170.00 178.00 191.00 N4 188.00 232.00 236.00 225.00 247.00 225.00
H5 174.00 104.00 121.00 132.00 159.00 188.00 N5 232.00 287.00 287.00 263.00 287.00 301.00
H6 187.00 174.00 186.00 209.00 206.00 206.00 N6 190.00 193.00 172.00 210.00 117.00 138.00
H7 305.00 311.00 319.00 319.00 286.00 317.00 N7 210.00 216.00 222.00 221.00 271.00 264.00
H8 213.00 195.00 205.00 212.00 237.00 247.00 N8 254.00 250.00 296.00 336.00 334.00 324.00
Mean 205.38 184.13 208.25 216.38 223.50 236.63 241.38 248.88 265.25 277.50 275.75 272.88
SD 47.68 67.56 59.61 57.16 46.31 45.97 49.89 38.01 52.08 56.55 70.62 63.86
SEM 16.86 23.88 21.07 20.21 16.37 16.25 17.64 13.44 18.41 19.99 24.97 22.58
t test time 0.23 0.04 0.01 0.33 0.03 0.54 0.09 0.19 0.91 0.61
t test group 0.08 0.10 0.08 0.09 0.18
Percent Change for Isometric Peak Strength at 55 deg of Knee Flexion
 
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 -50.46 83.33 4.04 4.85 11.57 N1 0.00 -16.93 -2.24 -1.60 -2.56 -0.32
H2 0.00 10.85 10.64 3.85 7.04 -1.04 N2 0.00 5.24 18.34 29.26 37.55 29.26
H3 0.00 -2.06 10.53 1.43 1.88 0.00 N3 0.00 -0.95 5.40 14.60 4.76 2.54
H4 0.00 11.43 7.05 1.80 4.71 7.30 N4 0.00 23.40 25.53 19.68 31.38 19.68
H5 0.00 -40.23 16.35 9.09 20.45 18.24 N5 0.00 23.71 23.71 13.36 23.71 29.74
H6 0.00 -6.95 6.90 12.37 -1.44 0.00 N6 0.00 1.58 -9.47 10.53 -38.42 -27.37
H7 0.00 1.97 2.57 0.00 -10.34 10.84 N7 0.00 2.86 5.71 5.24 29.05 25.71
H8 0.00 -8.45 5.13 3.41 11.79 4.22 N8 0.00 -1.57 16.54 32.28 31.50 27.56
Mean 0.00 -10.49 17.81 4.50 4.87 6.39 0.00 4.67 10.44 15.42 14.62 13.35
SD 0.00 26.33 26.80 4.36 9.07 6.86 0.00 13.44 12.58 11.44 25.60 20.28
SEM 0.00 9.31 9.48 1.54 3.21 2.43 0.00 4.75 4.45 4.04 9.05 7.17
t test time 0.24 0.13 0.21 0.91 0.66 0.36 0.13 0.23 0.92 0.64
t test group 0.10 0.55 0.04 0.30 0.33
Isometric Peak Strength (Nm/kg) at 35 deg of Knee Flexion   
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 141.00 138.00 137.00 155.00 165.00 213.00 N1 220.00 214.00 226.00 217.00 232.00 213.00
H2 146.00 151.00 159.00 176.00 198.00 186.00 N2 163.00 188.00 206.00 202.00 214.00 212.00
H3 118.00 137.00 129.00 134.00 137.00 138.00 N3 209.00 217.00 239.00 248.00 221.00 214.00
H4 111.00 107.00 104.00 98.00 108.00 108.00 N4 138.00 155.00 164.00 165.00 184.00 170.00
H5 145.00 83.00 104.00 96.00 122.00 140.00 N5 152.00 193.00 187.00 178.00 184.00 198.00
H6 138.00 113.00 132.00 159.00 156.00 152.00 N6 157.00 149.00 141.00 167.00 156.00 144.00
H7 236.00 232.00 220.00 220.00 243.00 236.00 N7 141.00 144.00 174.00 138.00 199.00 202.00
H8 213.00 213.00 213.00 213.00 213.00 213.00 N8 209.00 220.00 232.00 250.00 271.00 285.00
Mean 156.00 146.75 149.75 156.38 167.75 173.25 173.63 185.00 196.13 195.63 207.63 204.75
SD 44.54 51.59 44.91 46.60 46.87 45.23 33.47 31.71 35.37 40.68 35.23 40.70
SEM 15.75 18.24 15.88 16.48 16.57 15.99 11.84 11.21 12.51 14.38 12.45 14.39
t test time 0.32 0.50 0.18 0.02 0.45 0.09 0.05 0.94 0.23 0.54
t test group 0.12 0.04 0.10 0.04 0.07
Percent Change for Isometric Peak Strength at 35 deg of Knee Flexion
Hypoxia Group Normoxia Group
Subject 0 24 48 72 96 120 Subject 0 24 48 72 96 120
H1 0.00 -2.13 -2.84 9.93 17.02 51.06 N1 0.00 -2.73 2.73 -1.36 5.45 -3.18
H2 0.00 3.42 8.90 20.55 35.62 27.40 N2 0.00 15.34 26.38 23.93 31.29 30.06
H3 0.00 16.10 9.32 13.56 16.10 16.95 N3 0.00 3.83 14.35 18.66 5.74 2.39
H4 0.00 -3.60 -6.31 -11.71 -2.70 -2.70 N4 0.00 12.32 18.84 19.57 33.33 23.19
H5 0.00 -42.76 -28.28 -33.79 -15.86 -3.45 N5 0.00 26.97 23.03 17.11 21.05 30.26
H6 0.00 -18.12 -4.35 15.22 13.04 10.14 N6 0.00 -5.10 -10.19 6.37 -0.64 -8.28
H7 0.00 -1.69 -6.78 -6.78 2.97 0.00 N7 0.00 2.13 23.40 -2.13 41.13 43.26
H8 0.00 0.00 0.00 0.00 0.00 0.00 N8 0.00 5.26 11.00 19.62 29.67 36.36
Mean 0.00 -6.10 -3.79 0.87 8.27 12.43 0.00 7.25 13.69 12.72 20.88 19.26
SD 0.00 17.53 11.73 17.95 15.62 19.02 0.00 10.52 12.35 10.24 15.50 19.52
SEM 0.00 6.20 4.15 6.35 5.52 6.72 0.00 3.72 4.37 3.62 5.48 6.90
t test time 0.36 0.45 0.19 0.02 0.41 0.09 0.07 0.83 0.21 0.54
t test group 0.17 0.03 0.16 0.19 0.59
